Benefytt (BFYT) 10-Q 19 Nov 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Nov. 14, 2014	Nov. 14, 2014
		Class A common stock	Class B common stock
Entity Information [Line Items]	'	'	'
Document Type	'10-Q	'	'
Amendment Flag	'false	'	'
Document Period End Date	30-Sep-14	'	'
Document Fiscal Year Focus	'2014	'	'
Document Fiscal Period Focus	'Q3	'	'
Trading Symbol	'HIIQ	'	'
Entity Registrant Name	'Health Insurance Innovations, Inc.	'	'
Entity Central Index Key	'0001561387	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Common Stock, Shares Outstanding	'	7,846,759	6,841,667

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
Current assets:	'	'
Cash and cash equivalents	$12,470,000	$17,054,000
Cash held on behalf of others	8,379,000	4,591,000
Investment proceeds receivable	'	15,000,000
Short-term investments	1,843,000	6,877,000
Accounts receivable, net, prepaid expenses and other current assets	2,112,000	963,000
Advanced commissions	5,608,000	2,596,000
Income taxes receivable	532,000	395,000
Deferred tax asset	74,000	'
Total current assets	31,018,000	47,476,000
Property and equipment, net	493,000	389,000
Goodwill	38,422,000	18,014,000
Intangible assets, net	14,207,000	5,281,000
Other assets	192,000	489,000
Total assets	84,332,000	71,649,000
Current liabilities:	'	'
Accounts payable and accrued expenses	12,278,000	7,074,000
Current portion of contingent acquisition consideration	2,686,000	1,945,000
Deferred revenue	73,000	882,000
Current portion of due to member	229,000	916,000
Other current liabilities	186,000	187,000
Total current liabilities	15,452,000	11,004,000
Contingent acquisition consideration	2,000,000	1,931,000
Due to member	387,000	423,000
Other liabilities	379,000	514,000
Total liabilities	18,218,000	13,872,000
Commitments and contingencies	'	'
Stockholdersb equity:	'	'
Preferred stock (par value $0.001 per share, 5,000,000 shares authorized; no shares issued and outstanding)	'	'
Additional paid-in capital	56,815,000	28,787,000
Treasury stock, at cost (2,167 and 129,881 shares, respectively)	-27,000	-1,563,000
Accumulated deficit	-3,768,000	-3,355,000
Total Health Insurance Innovations, Inc. stockholders' equity	53,035,000	23,883,000
Noncontrolling interests	13,079,000	33,894,000
Total stockholders' equity	66,114,000	57,777,000
Total liabilities and stockholders' equity	84,332,000	71,649,000
Class A common stock	'	'
Stockholdersb equity:	'	'
Common stock	8,000	5,000
Total stockholders' equity	8,000	5,000
Class B common stock	'	'
Stockholdersb equity:	'	'
Common stock	7,000	9,000
Total stockholders' equity	$7,000	$9,000

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Treasury stock, shares	2,167	129,881
Class A common stock	'	'
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	7,850,585	5,309,594
Common stock, shares outstanding	7,848,418	5,179,713
Class B common stock	'	'
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	6,841,667	8,566,667
Common stock, shares outstanding	6,841,667	8,566,667

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Statement [Abstract]	'	'	'	'
Revenues (premium equivalents of $42,240 and $25,977 for the three months ended September 30, 2014 and 2013, respectively and $110,375 and $72,256 for the nine months ended September 30, 2014 and 2013, respectively)	$23,364	$14,749	$62,228	$40,818
Cost of revenues	-397	'	-397	'
Gross margin	22,967	14,749	61,831	40,818
Operating expenses:	'	'	'	'
Third-party commissions	11,377	7,928	30,577	24,438
Credit cards and ACH fees	534	313	1,367	861
Contract termination	'	'	'	5,500
Selling, general and administrative	10,990	6,348	27,478	16,010
Depreciation and amortization	907	423	1,723	913
Total operating expenses	23,808	15,012	61,145	47,722
(Loss) income from operations	-841	-263	686	-6,904
Other expense (income):	'	'	'	'
Interest (income) expense	'	-7	-17	14
Other expense	275	53	957	437
Net loss before income taxes	-1,116	-309	-254	-7,355
(Benefit) provision for income taxes	-332	-823	-205	472
Net (loss) income	-784	514	-49	-7,827
Net (loss) income attributable to noncontrolling interests	-172	106	364	-4,143
Net (loss) income attributable to Health Insurance Innovations, Inc.	($612)	$408	($413)	($3,684)
Net (loss) income per share attributable to Health Insurance Innovations, Inc.	'	'	'	'
Basic	($0.09)	$0.09	($0.07)	($0.77)
Diluted	($0.09)	$0.08	($0.07)	($0.77)
Weighted average Class A shares outstanding	'	'	'	'
Basic	6,532,161	4,795,736	5,538,422	4,768,294
Diluted	6,532,161	4,861,336	5,538,422	4,768,294

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements Of Operations (Parenthetical) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Statement [Abstract]	'	'	'	'
Premium equivalent amount	$42,240	$25,977	$110,375	$72,256

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Stockholders' Equity (USD $)

Total

Class A common stock

Class B common stock

Noncontrolling Interests

Additional Paid-in Capital

Additional Paid-in Capital

Treasury Stock

Accumulated Deficit

Initial public offering

Initial public offering

Initial public offering

Initial public offering

Initial public offering

Initial public offering

Underwriters exercise of over-allotment options

Underwriters exercise of over-allotment options

Underwriters exercise of over-allotment options

Private Placement

Private Placement

Private Placement

Pre IPO

Pre IPO

In Thousands, except Share data

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Class A common stock

USD ($)

USD ($)

USD ($)

Class A common stock

Class B common stock

Noncontrolling Interests

Additional Paid-in Capital

Additional Paid-in Capital

USD ($)

Class A common stock

Additional Paid-in Capital

USD ($)

Class A common stock

Additional Paid-in Capital

Health Plan Intermediaries, LLC and Subsidiaries

Noncontrolling Interests

USD ($)

USD ($)

USD ($)

USD ($)

Class A common stock

Class B common stock

Class A common stock

USD ($)

Class A common stock

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Beginning balance at Dec. 31, 2012

$6,338

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$6,335

$3

Net (loss) income

-259

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-248

-11

Contributions

10

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10

Distributions

-171

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-171

'

Ending balance at Feb. 11, 2013

5,918

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,916

2

Effects of initial public offering and reorganization

'

'

'

5,918

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-5,916

-2

Issuance of common stock, shares

'

'

'

'

'

'

'

'

'

4,666,667

8,666,667

'

'

'

'

'

'

'

'

'

'

'

Ending balance at Feb. 13, 2013

5,918

'

'

5,918

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net (loss) income

-8,160

'

'

-4,805

'

'

'

-3,355

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Contributions

6

'

'

6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Distributions

-2,217

'

'

-2,217

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock

'

'

'

'

'

'

'

'

57,755

5

9

36,444

57,750

-36,453

1,400

'

1,400

'

'

'

'

'

Issuance of common stock, shares

'

'

'

'

'

'

'

'

'

4,666,667

8,666,667

'

'

'

'

100,000

'

'

'

'

'

'

Purchase of Series B Membership interests and exchange and cancellation of Class B common stock

-1,400

'

'

-1,400

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Purchase of Series B Membership interests and exchange and cancellation of Class B common stock, shares

'

'

-100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of Class A common stock under equity compensation plans

6,296

'

'

'

'

6,296

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of Class A common stock under equity compensation plans, shares

'

542,927

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of restricted shares from treasury

'

'

'

'

-2,408

'

2,408

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of restricted shares from treasury, shares

'

'

'

'

'

'

-182,964

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class A common stock transferred to treasury

-1,731

'

'

'

'

'

-1,731

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class A common stock transferred to treasury, shares

'

-129,881

'

'

'

'

152,845

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Forfeiture of restricted shares held in treasury

'

'

'

'

2,240

'

-2,240

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Forfeiture of restricted stock held in treasury, shares

'

'

'

'

'

'

160,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Acquisition of noncontrolling interest in consolidated subsidiary

-90

'

'

-52

-38

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Ending balance at Dec. 31, 2013

57,777

5

9

33,894

28,787

'

-1,563

-3,355

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Ending balance, Shares at Dec. 31, 2013

'

5,179,713

8,566,667

'

'

'

129,881

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net (loss) income

-49

'

'

364

'

'

'

-413

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Distributions

-222

'

'

-222

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20,959

2

20,957

'

'

Issuance of common stock, shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,725,000

'

'

'

Purchase of Series B Membership interests and exchange and cancellation of Class B common stock

-20,959

'

-2

-20,957

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Purchase of Series B Membership interests and exchange and cancellation of Class B common stock, shares

'

'

-1,725,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of restricted shares from treasury

'

'

'

'

-1,793

'

1,793

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of restricted shares from treasury, shares

'

150,000

'

'

'

'

-150,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class A common stock transferred to treasury

-257

'

'

'

'

'

-257

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class A common stock transferred to treasury, shares

'

-10,744

'

'

'

'

10,744

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Forfeiture of restricted shares held in treasury

131

-11,542

'

'

131

'

11,542

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class A common stock issued to purchase subsidiary

7,126

1

'

'

'

7,125

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class A common stock issued to purchase subsidiary, shares

'

815,991

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock compensation expense

1,608

'

'

'

1,608

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Ending balance at Sep. 30, 2014

$66,114

$8

$7

$13,079

$56,815

'

($27)

($3,768)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Ending balance, Shares at Sep. 30, 2014

'

7,848,418

6,841,667

'

'

'

2,167

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (unaudited) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Operating activities:	'	'
Net loss	($49,000)	($7,827,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:	'	'
Stock-based compensation	1,608,000	4,276,000
Depreciation and amortization	1,723,000	913,000
Loss on extinguishment of debt and amortization of deferred financing costs	0	78,000
Fair value adjustments to contingent acquisition consideration	939,000	64,000
Gain on sale of available-for-sale securities	-20,000	0
Benefit for deferred income taxes	-74,000	0
Changes in operating assets and liabilities:	'	'
Increase in cash held on behalf of others	-3,788,000	-233,000
(Increase) decrease in accounts receivable, prepaid expenses and other assets	-575,000	43,000
Increase in income taxes receivable	-137,000	0
Increase in advanced commissions	-3,012,000	-1,135,000
Increase (decrease) in accounts payable, accrued expenses and other liabilities	4,419,000	-666,000
(Decrease) increase in deferred revenue	-902,000	595,000
Increase in income taxes payable	0	74,000
Increase in due to member pursuant to tax receivable agreement	193,000	374,000
Net cash provided by (used in) operating activities	325,000	-3,444,000
Investing activities:	'	'
Business acquisition, net of cash acquired	-21,978,000	-9,909,000
Proceeds from sale of available-for sale securities	33,020,000	0
Acquisition of available-for-sale securities	-18,000,000	-21,414,000
Proceeds from maturities of held-to-maturity securities	5,494,000	0
Payments for deposits	-500,000	-9,000
Purchases of property and equipment	-210,000	-113,000
Net cash used in investing activities	-2,174,000	-31,445,000
Financing activities:	'	'
Issuance of Class A common stock in private offering	20,959,000	0
Purchase of Series B Membership interests	-20,959,000	-1,302,000
Distributions to member	-1,138,000	-1,617,000
Payment of contingent acquisition consideration	-1,350,000	0
Class A common stock forfeited and withheld in treasury from restricted share vesting	-126,000	-377,000
Payments for long-term debt and noncompete obligation	-121,000	-3,466,000
Payments for equity issuance	0	-1,643,000
Acquisition of noncontrolling interest in subsidiary	0	-90,000
Contributions from noncontrolling interests	0	16,000
Net cash (used in) provided by financing activities	-2,735,000	53,583,000
Net (decrease) increase in cash and cash equivalents	-4,584,000	18,694,000
Cash and cash equivalents at beginning of period	17,054,000	750,000
Cash and cash equivalents at end of period	12,470,000	19,444,000
Supplemental Disclosure of non-cash investing activities:	'	'
Contingent consideration for business acquisition	1,270,000	4,937,000
Consideration for business acquisition included in accrued expenses	217,000	0
Adjustment to consideration for business acquisition included in accounts receivable	12,000	0
Class A common stock	'	'
Financing activities:	'	'
Issuance of common stock in initial public offering	0	60,760,000
Class A common stock | Underwriters Over Allotment Option	'	'
Financing activities:	'	'
Issuance of common stock in initial public offering	$0	$1,302,000

Organization_Basis_of_Presenta

Organization, Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2014
Organization Consolidation And Presentation Of Financial Statements [Abstract]	'
Organization, Basis of Presentation and Summary of Significant Accounting Policies	'
	1. Organization, Basis of Presentation and Summary of Significant Accounting Policies
	In this quarterly report, unless the context suggests otherwise, references to the “Company,” “we,” “us” and “our” refer (1) prior to the February 13, 2013 initial public offering (“IPO”) of the Class A common stock of Health Insurance Innovations, Inc. and related transactions, to Health Plan Intermediaries, LLC (“HPI”) and its consolidated subsidiaries and (2) after the IPO and related transactions, to Health Insurance Innovations, Inc. and its consolidated subsidiaries. The terms “HII”, “HPIH”, and “ICE” refer to the stand-alone entities Health Insurance Innovations, Inc., Health Plan Intermediaries Holdings, LLC, and Insurance Center for Excellence, LLC, respectively. The term “Secured” refers to (a) prior to or at the time of their July 17, 2013 acquisition by us, Sunrise Health Plans, Inc., Sunrise Group Marketing, Inc. and Secured Software Solutions, Inc., collectively, and (b) following our July 17, 2013 acquisition, the entities described in (a) and the limited liability companies into which such entities were converted shortly following such acquisition. The term “SIL” refers to Simple Insurance Leads, LLC, a partially owned venture we formed on October 7, 2013. The term “HP” refers to HealthPocket, Inc., a wholly owned subsidiary which was acquired by HPIH on July 14, 2014.  The term “ASIA” refers to American Service Insurance Agency, LLC, a wholly owned subsidiary which was acquired by HPIH on August 8, 2014. HPIH, ICE, Secured, SIL, HP and ASIA are consolidated subsidiaries of HII.
	Business Description and Organizational Structure of the Company
	Our Business
	We are a developer and administrator of affordable individual health insurance and discount benefit plans that are sold throughout the United States. The main product we sell, Short Term Medical (“STM”) insurance, is an alternative to Patient Protection and Affordable Care Act (“PPACA”)-qualified individual major medical plans and generally offers comparable benefits for qualifying individuals. We also offer guaranteed-issue hospital indemnity plans for individuals under the age of 65 and a variety of ancillary products that are frequently purchased together with the STM and hospital indemnity plans as supplements. We design and structure insurance products on behalf of our contracted insurance carrier companies, market them to individuals through a network of distributors, and manage the member relationship through customer service agents. Our sales are primarily executed online and offer real-time fulfillment through a proprietary web-based technology platform, through which we receive credit card and automated clearing house (“ACH”) payments directly from the purchasing customers, whom are also referred to as members, at the time of sale. The plans are underwritten by contracted insurance carrier companies, and we assume no underwriting or insurance risk.
	Our History
	Our business began operations in 2008, and historically we operated through HPI. HII was incorporated in the State of Delaware in October 2012 to facilitate the IPO. Further, through a series of transactions, HPI assigned the operating assets of our business to HPIH, and HPIH assumed the operating liabilities of HPI. Since November 2012, we have operated our business through HPIH and its consolidated subsidiaries. See Note 6 for more information about the IPO.
	Upon completion of the IPO, HII became a holding company, the principal asset of which is its interest in HPIH. All of HII’s business is conducted through HPIH and its subsidiaries. HII is the sole managing member and has 100% of the voting rights and control of HPIH.
	Basis of Presentation
	The condensed consolidated financial statements reflect the results of operations of HPI through the closing of the IPO on February 13, 2013, and the Company subsequent to the IPO. Intercompany accounts and transactions have been eliminated in consolidation.
	Noncontrolling interests are included in the consolidated balance sheets as a component of stockholders’ equity that is not attributable to the equity of the Company. We report separately the amounts of consolidated net loss or income attributable to us and noncontrolling interests.
	As an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), we take advantage of certain temporary exemptions from various reporting requirements, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act and reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. We have also elected to delay the adoption of new and revised accounting standards until those standards would otherwise apply to nonpublic entities. Our financial statements may therefore not be comparable to those of companies that comply with such new or revised accounting standards. These exemptions will apply for a period of five years following the completion of our IPO. However, if the market value of our common stock that is held by non-affiliates exceeds $700 million as of any June 30 before that time, we would cease to be an emerging growth company as of the following December 31.
	The information included in this Quarterly Report on Form 10-Q, including the interim condensed consolidated financial statements and the accompanying notes, should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.
	Reclassifications
	Certain amounts in the prior period’s consolidated financial statements have been reclassified to conform to the current period presentation. Such reclassifications include short-term loans receivable into advanced commissions; carriers and vendors payable and commissions payable into accounts payable and accrued expenses; and the long-term portion of the noncompete obligation into other liabilities in the accompanying consolidated balance sheets.
	Use of Estimates
	The accompanying unaudited interim condensed consolidated financial statements of the Company include all normal recurring accruals and adjustments considered necessary by management for their fair presentation in conformity with accounting principles generally accepted in the United States of America (“GAAP”). Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates. The consolidated results of operations for the three and nine months ended September 30, 2014 are not necessarily indicative of results that may be expected for the year ending December 31, 2014 or any future interim period.
	Summary of Significant Accounting Policies
	Our significant accounting policies are described in Note 1, Organization, Basis of Presentation, and Summary of Significant Accounting Policies, in our audited consolidated financial statements for the year ended December 31, 2013 in our Form 10-K.
	Recent Accounting Pronouncements
	In the following summary of recent accounting pronouncements, all references to effective dates of Financial Accounting Standards Board (“FASB”) guidance relate to nonpublic entities. As noted above, we have elected to delay the adoption of new and revised accounting standards until those standards would otherwise apply to nonpublic companies under provisions of the JOBS Act.
	In May 2014, the FASB issued an amendment to its accounting guidance related to revenue recognition. The amendment clarifies the principles for recognizing revenue. The guidance is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in the judgments and assets recognized from costs incurred to obtain or fulfill a contract. We will adopt this guidance in reporting periods beginning after December 15, 2017. We are currently evaluating the impact of adopting this pronouncement on our consolidated financial statements.
	In July 2013, the FASB issued guidance which states that a liability for uncertain tax positions, or a portion of a liability for uncertain tax provisions, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available as of the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, liability for uncertain tax positions should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The assessment of whether a deferred tax asset is available is based on the uncertain tax position and deferred tax asset that exist at the reporting date and should be made presuming disallowance of the tax position at the reporting date. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2014, with early adoption permitted. We plan to adopt this guidance during the quarter ended March 31, 2015, but we do not anticipate that it will have a significant impact on our consolidated financial statements.

Business_Acquisitions

Business Acquisitions	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Business Acquisitions	'
	2. Business Acquisitions
	Acquisition of HealthPocket, Inc.
	On July 14, 2014, we entered into an agreement to acquire (the “Merger Agreement”) HealthPocket, Inc. (which is referred to herein as “HP”) from Mr. Bruce Telkamp (“Telkamp”), Dr. Sheldon Wang (“Wang”) and minority equity holders of HP. The closing of the acquisition occurred on July 14, 2014 simultaneous with the signing of the Merger Agreement.
	Pursuant to the Merger Agreement, at the closing, we paid consideration consisting of approximately $21.9 million in cash and 900,900 shares of  Class A common stock, $0.001 par value per share, with such shares of the  Class A common stock having an agreed upon aggregate value of $10.0 million, or $11.10 per share. A portion of the merger consideration consisting of $3.2 million in cash was deposited with an escrow agent to fund payment obligations with respect to post-closing working capital adjustments, post-closing indemnification obligations of HP’s former equity holders, and fees and expenses of the representative of HP’s former equity holders.
	All vested options and warrants to acquire shares of HP’s capital stock were terminated in connection with the acquisition, and the holders thereof will receive in cash a portion of the aggregate consideration upon the terms and subject to the conditions set forth in the Merger Agreement. All unvested options to acquire shares of HP’s capital stock were converted into options to acquire shares of our Class A Common Stock (“Replacement Options”) upon the terms and subject to the conditions set forth in the Merger Agreement. The total number of Replacement Options was 84,909. Pursuant to the Merger Agreement, this amount offset the total number of shares included in the consolidation. If any Replacement Options are terminated or expire, the value of those options will be classified as an adjustment to the purchase price for the acquisition. The Replacement Options are included as a component of stock-based compensation on the accompanying condensed consolidated statements of operations. See Note 7 for future information on the Replacement Options. As of September 30, 2014, the net amount of shares of Class A common stock issued as a result of the acquisition was 815,991.
	Under the terms of the Merger Agreements, the former equity holders of HP may elect to receive cash or shares of our Class A common stock. Telkamp and Wang have agreed to accept cash and common stock, including 50% each of any of the shares that were issued as part of the aggregate consideration that are not elected to be received as consideration by other former HP equity holders.
	Effective July 14, 2014, HII's Board of Directors appointed Telkamp as our Chief Operating Officer and we entered into an employment agreement Mr. Telkamp where he also agreed to continue to serve as HealthPocket’s Chief Executive Officer.   Telkamp’s employment agreement provides for, among other things, a noncompetition covenant beginning on July 14, 2014 and ending on the last day of any salary continuation period (as defined in Telkamp’s employment agreement).  In addition, the Merger Agreement provides for, among other things, a noncompetition covenant applicable to Telkamp beginning on July 14, 2014 and ending on July 14, 2017.  Telkamp was also appointed as a member of HII’s Board of Directors. In addition, effective July 14, 2014, HII’s Board of Directors appointed Wang as our Chief Technology Officer and we entered into an employment agreement with Wang where he also agreed to continue to serve as HealthPocket’s President.  Wang’s employment agreement provides for, among other things, a noncompetition covenant beginning on July 14, 2014 and ending on the last day of any salary continuation period (as defined in Wang’s employment agreement).  In addition, the Merger Agreement provides for, among other things, a noncompetition covenant applicable to Wang beginning on July 14, 2014 and ending on July 14, 2017.
	During the three and nine months ended September 30, 2014, we recognized $433,000 and $520,000, respectively, in transaction costs related to HP. Transaction costs were expensed as incurred and are included in selling, general and administrative expenses in the accompanying condensed consolidated statements of operations. We expect to incur additional acquisition related costs in the fourth quarter of 2014.
	This transaction is expected to provide us with additional benefits such as increased and ongoing sales referrals that we will own, broad consumer and industry data to facilitate our entry into new markets and revenue streams, advanced health information technology to position us to better assist our stakeholders, including customers, insurance brokers and insurance carriers, and other technological and operational synergies.
	The following table summarizes the fair value of the consideration for the acquisition as of July 14, 2014 ($ in thousands):
	Cash paid at closing (1)	$	21,906
	Class A common stock, at fair value (2)		7,126
	Total consideration	$	29,032
	-1	Cash paid at closing includes $17.0 million in cash, $3.2 million in cash held in escrow, as noted above, $1.2 million for the payoff of outstanding bank debt held by HP, $54,000 for the payoff of HP loans payable to Telkamp and Wang, and $482,000 in estimated acquisition-related expenses incurred by HP.
	-2	The fair value of the Class A common stock derived from the market price of the stock, adjusted to include a discount for a lack of marketability, due to trading restrictions pursuant to the Merger Agreement and other factors.
	The following table summarizes the preliminary allocation of the total purchase price for the acquisition as of July 14, 2014 ($ in thousands):
	Cash	$	1,295
	Accounts receivable and other assets (1)		103
	Property and equipment (1)		7
	Accounts payable, accrued expenses and other liabilities (1)		(486	)
	Intangible asset – technology		8,100
	Intangible asset – brand		1,280
	Intangible asset – customer relationships		430
	Intangible asset – noncompete agreements		27
	Goodwill (2)		18,276
		$	29,032
	-1	The carrying value of accounts receivable, accounts payable, accrued expenses and property and equipment approximated fair value; as such, no adjustments to the accounts were recorded in association with the acquisition.
	-2	As of September 30, 2014, we expect none of the goodwill acquired in this transaction to be deductible.
	The goodwill allocated to the purchase price was calculated as the fair value of the consideration less the assets acquired and liabilities assumed. This value is primarily related to the expected results of future operations of HP and the operational and technological synergies we expect to realize as a result of the acquisition.
	As a result of acquiring HP, our consolidated results of operations include the results of HP since the acquisition date. HP’s revenues and pre-tax net loss included in our results of operations since the acquisition were $370,000 and $1.4 million, respectively, for the three and nine months ended September 30, 2014. Net loss before taxes include $459,000 of amortization expense related to the identified intangible assets recorded as a result of the acquisition.
	The following table ($ in thousands) presents unaudited pro forma information for the Company assuming the acquisition of HP had occurred as of January 1, 2013. This pro forma information does not purport to represent what our actual results would have been if the acquisition had occurred as of the date indicated or what such results would be for any future periods.
		($ in thousands, except per share data)
		Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Revenues	$	23,409		$	14,749		$	62,936		$	40,818
	Net loss before income taxes		(788	)		(1,706	)		(2,175	)		(11,637	)
	Net loss		(554	)		(1,815	)		(420	)		(12,382	)
	Net loss attributable to Health Insurance Innovations, Inc.		(582	)		(1,055	)		(728	)		(5,584	)
	Loss per share – basic		(0.09	)		(0.22	)		(0.13	)		(1.17	)
	Loss per share – diluted		(0.09	)		(0.22	)		(0.13	)		(1.17	)
	Acquisition of American Service Insurance Agency, LLC
	On August 8, 2014, we entered into an agreement (the “Purchase Agreement”) to acquire all of the issued and outstanding membership interests of American Service Insurance Agency, LLC, a Texas insurance brokerage (“ASIA”), from Mr. Landon Jordan (Jordan) for an initial cash payment of $1.8 million, comprised of a prior deposit of $325,000 and a closing payment of $1.5 million, and $2.2 million in contingent consideration, as described below.  The closing of the acquisition occurred on August 8, 2014 simultaneous with the signing of the Purchase Agreement.
	Pursuant to the Purchase Agreement, Jordan may receive total contingent consideration of $2.2 million, payable in cash.  This amount is payable in two cash payments of $1.2 million and $1.0 million, respectively, if ASIA attains certain amounts of adjusted EBITDA, as defined by the Purchase Agreement, during each of the periods from September 1, 2014 through August 31, 2015, and September 1, 2015 through August 31, 2016.  As of September 30, 2014, the fair value of the contingent consideration was $1.3 million which is included in contingent acquisition consideration on the accompanying condensed consolidated balance sheets  During the three months ended September 30, 2014, we recorded $50,000 in adjustments to the fair value of the contingent consideration, primarily due to the discounting of the future payments. The estimated range of potential total contingent consideration is zero to approximately $2.2 million.
	Effective August 8, 2014, we also entered into an employment agreement with Jordan which provides for, among other things, a noncompetition covenant beginning on August 8, 2014 and ending on the later of August 8, 2017 and one year following the date on which Jordan’s employment with us is terminated.
	We recognized $13,000 and $48,000 during each of the three and nine months ended September 30, 2014 in transaction costs related to ASIA. Transaction costs were expensed as incurred and are included in selling, general and administrative expenses in the accompanying condensed consolidated statements of operations. We expect to incur additional acquisition related costs in the fourth quarter of 2014.
	The following table summarizes the fair value of the consideration for the acquisition as of August 8, 2014 ($ in thousands):
	Cash paid at closing	$	1,825
	Contingent consideration, at fair value		1,220
	Total consideration	$	3,045
	The following table summarizes the preliminary allocation of the total purchase price for the acquisition as of August 8, 2014 ($ in thousands):
	Cash	$	105
	Accounts receivable and other assets (1)		272
	Accounts payable, accrued expenses and other liabilities  (1)		(164	)
	Intangible asset – customer relationships – distributors		406
	Intangible asset – customer relationships – direct		257
	Intangible asset – brand		20
	Intangible asset – noncompete agreements		17
	Goodwill (2)		2,132
		$	3,045
	-1	The carrying value of accounts receivable, accounts payable, accrued expenses and property and equipment approximated fair value; as such, no adjustments to the accounts were recorded in association with the acquisition.
	-2	As of September 30, 2014, the amount of goodwill acquired that we expect to be deductible for income tax purposes is $2.1 million.
	The goodwill allocated to the purchase price was calculated as the fair value of the consideration less the assets acquired and liabilities assumed. This value is primarily related to expected results of future operations of ASIA and the operational and technological synergies we expect to realize as a result of the acquisition.
	As a result of acquiring ASIA, our consolidated results of operations include the results of ASIA since the acquisition date. ASIA’s revenues and pre-tax net loss included in our results of operations since the acquisition were $292,000 and $300,000, respectively, for the three and nine months ended September 30, 2014. Net loss before taxes include $29,000 of amortization expense related to the identified intangible assets recorded as a result of the acquisition.
The following table ($ in thousands) presents unaudited pro forma information for the Company assuming the acquisition of ASIA had occurred as of January 1, 2013. This pro forma information does not purport to represent what our actual results would have been if the acquisition had occurred as of the date indicated or what such results would be for any future periods.
	($ in thousands, except per share data)
	Three months ended September 30,						Nine months ended September 30,
	2014			2013			2014			2013
Revenues	$	23,588		$	15,230		$	63,328		$	42,034
Net loss before income taxes		(1,258	)		(168	)		(244	)		(6,988	)
Net (loss) income		(884	)		(179	)		(47	)		(7,435	)
Net (loss) income attributable to Health Insurance Innovations, Inc.		(624	)		(372	)		(355	)		(3,520	)
(Loss) income per share – basic		(0.10	)		(0.08	)		(0.06	)		(0.74	)
(Loss) income per share – diluted		(0.10	)		(0.08	)		(0.06	)		(0.74	)
Acquisition of Sunrise Health Plans, Inc. and Affiliates
On July 17, 2013, we consummated a Stock Purchase Agreement with Joseph Safina, Howard Knaster and Jorge Saavedra (collectively, the “Sellers”), pursuant to which we acquired from the Sellers all of the outstanding equity of Sunrise Health Plans, Inc., a licensed insurance broker, Sunrise Group Marketing, Inc., a call center and sales lead management company, and Secured Software Solutions, Inc., an intellectual property holding company (collectively “Secured”), each of which was converted to a limited liability company shortly after closing, for a cash payment of $10.0 million plus $6.6 million of contingent consideration, which included contingent stock awards and a note payable. The Company also entered into employment agreements with the Sellers. The funding of the $10.0 million cash portion of the purchase price was provided primarily from the net proceeds from the IPO.
In November 2013, HPIH and the Sellers reached an agreement to modify the contingent consideration, including the thresholds to earn such contingent consideration, and to terminate the contingent stock awards and note payable. As a result of this agreement, the contingent consideration is payable in cash only. The contingent consideration included a one-time payment of $1.0 million, which was paid in November 2013. A fixed component in the aggregate of $250,000 will be paid quarterly if certain levels of policies in force, as defined by the amendment, are achieved, up to a maximum of $3.0 million. A variable component of no more than $200,000 per quarter will be paid if certain levels of growth in policies in force are achieved, up to a maximum of $2.4 million. In addition, one of the Sellers who severed his employment with Sunrise Health Plans, Inc. entered into a consulting arrangement with the Company. Contingent consideration also includes a potential payment of $150,000 to compensate the Sellers for personal income tax liability triggered by the acquisition. As of September 30, 2014, we had made total payments of $2.8 million under the contingent consideration agreement, and the maximum remaining payments under the agreement total $3.8 million.  The estimated range of potential total contingent consideration is approximately $2.8 million to $6.6 million.
The fair value of contingent consideration was $3.4 million as of September 30, 2014 and is included in contingent acquisition consideration on the accompanying condensed consolidated balance sheets. During the three and nine months ended September 30, 2014, we recorded $81,000 and $890,000, respectively, in adjustments to fair value of the contingent consideration, which is included in other expense on the accompanying condensed consolidated statements of operations. The increase in the fair value of the contingent consideration during the three months ended September 30, 2014 was primarily due to the accretion of the discount of the future payments. The increase for the nine months ended September 30, 2014 was primarily due to an increase in the estimated probability of the Sellers’ continuing to achieve the policies in force thresholds to earn the contingent consideration that will result in maximum payout under the agreement.
The following table summarizes the fair value of the consideration for the acquisition as of July 17, 2013 ($ in thousands). The fair values are derived using discount rates related to the probability of the Sellers’ meeting the thresholds for payment and other risk factors including credit risk.
Cash paid at closing	$	10,000
Contingent consideration		4,872
Total consideration	$	14,872
The following table summarizes the allocation of the total purchase prices for the acquisition as of July 17, 2013 ($ in thousands):
Cash	$	91
Accounts receivable and other assets (1)		332
Property and equipment (1)		128
Accounts payable and accrued expenses  (1)		(326	)
Intangible asset – brand		76
Intangible asset – noncompete agreements		99
Intangible asset – customer relationships-distributors		1,050
Intangible asset – customer relationships-direct		788
Intangible asset – capitalized software		526
Goodwill (2)		12,108
	$	14,872
-1	The carrying value of accounts receivable, property and equipment and accounts payable and accrued expenses acquired approximated fair value; as such, no adjustments to these accounts were recorded in association with the acquisition.
-2	As of September 30, 2014, the amount of goodwill acquired that we expect to be deductible for income tax purposes is $8.9 million.
The goodwill allocated to the purchase price was calculated as the fair value of the consideration less the assets acquired and liabilities assumed. This value is primarily related to expected results of future operations of Secured and the operational and technological synergies we expect to realize as a result of the acquisition.
The following table ($ in thousands) presents unaudited pro forma information for the Company assuming the acquisition of Secured had occurred as of January 1, 2013. This pro forma information does not purport to represent what our actual results would have been if the acquisition had occurred as of the date indicated or what such results would be for any future periods.
	Three months ended September 30, 2013			Nine months ended September 30, 2013
Revenues	$	15,162		$	43,383
Net income (loss) before income taxes		(209	)		(5,491	)
Net income (loss)		(226	)		(5,885	)
Net income (loss) attributable to Health Insurance Innovations, Inc.		(93	)		(1,219	)
Income (loss) per share – basic		(0.02	)		(0.26	)
Income (loss) per share – diluted		(0.02	)		(0.26	)
Acquisition of Insurance Center for Excellence, LLC
On June 1, 2012, HPI and TSG Agency, LLC (“TSG”) acquired ICE. ICE is a licensed call center and a call center training facility for our distributors. In connection with the transaction, HPI received an 80% controlling interest in ICE and TSG received a 20% noncontrolling interest in ICE. On June 30, 2013, we purchased TSG’s 20% interest in ICE for $90,000 and, as a result, ICE is our wholly-owned subsidiary.

Variable_Interest_Entities

Variable Interest Entities	9 Months Ended
	Sep. 30, 2014
Variable Interest Entity Measure Of Activity [Abstract]	'
Variable Interest Entities	'
	3. Variable Interest Entities
	As of September 30, 2014, we are the primary beneficiary of one entity that constitutes a variable interest entity (“VIE”) pursuant to FASB guidance.
	Simple Insurance Leads, LLC
	On October 7, 2013, HPIH entered into a Limited Liability Company Operating Agreement (the “SIL LLC Agreement”) with Health Benefits One, LLC (“HBO”) to form Simple Insurance Leads, LLC (“SIL”), a venture intended to procure sales leads for us and our distributors. We had made $469,000 in contributions to SIL as of September 30, 2014 and may be required to make total contributions of $492,000 under the SIL LLC Agreement. HBO had no obligations to make any initial capital contributions.
	Per the SIL LLC Agreement, so long as HPIH’s unreturned capital contributions have not been reduced to zero, HPIH may, without the consent of HBO, cause SIL to take any significant actions affecting SIL’s day-to-day operations, including the sale or disposition of SIL assets and entrance into voluntary liquidation or receivership of SIL. As such, we determined that we have the power to control the day-to-day activities of SIL.
	We have concluded that we are the primary beneficiary of SIL, and therefore, should consolidate SIL because we have power over and receive the benefits of SIL. We have the power to direct the activities of SIL that most significantly impact its economic performance. Per the terms of the SIL LLC Agreement, we have determined that 100% of the operating income or loss of the VIE should be allocated to us. As of September 30, 2014, our maximum exposure to loss as a result of our involvement in this VIE was 100% of our capital contributions to SIL, or $469,000, plus 100% of the operating income or loss of the VIE, as noted above.
	HPIH
	Prior to August 15, 2014, HII had a variable interest in HPIH as the non-HII members owned more than 50% of the membership and economic interest in HPIH. We concluded that we were the primary beneficiary of HPIH because we had power over HPIH by maintaining 100% of the voting power and received the benefits of HPIH.  As such, HPIH has been consolidated in our financial statements.
	On August 15, 2014, the non-HII of HPIH members exchanged 1,725,000 Class B Membership Units of HPIH (together with an equal number of shares of HII Class B common stock) in exchange for an equal number of Class A common stock pursuant to an Exchange Agreement (the “Exchange Agreement”).  See Note 6 for further information on the Exchange Agreement and this transaction.  This transaction resulted in HII obtaining greater than 50% of the membership and economic interest of HPIH.  As of September 30, 2014, HII holds 100% of the voting power and 53.4% of the membership and economic interest in HPIH.  As such, HPIH is no longer considered a variable interest entity.  HPIH remains consolidated in our financial statements, with the economic interests of the non-HII members included in noncontrolling interest.

Goodwill_and_Intangible_Assets

Goodwill and Intangible Assets	9 Months Ended
	Sep. 30, 2014
Goodwill And Intangible Assets Disclosure [Abstract]	'
Goodwill and Intangible Assets	'
	4. Goodwill and Intangible Assets
	Goodwill
	Our goodwill balance as of December 31, 2013 arose from previous acquisitions as described in our Form 10-K for the year ended December 31, 2013. Our goodwill balance as of September 30, 2014 arose from the HP and the ASIA acquisitions described in Note 2 as well as our goodwill balance existing as prior to such acquisition.
	The changes in the carrying amounts of goodwill were as follows ($ in thousands):
	Balance as of January 1, 2013	$	5,906
	Goodwill acquired		12,108
	Impairment of goodwill		—
	Balance as of December 31, 2013		18,014
	Goodwill acquired		20,408
	Impairment of goodwill		—
	Balance as of September 30, 2014	$	38,422
	Other Intangible Assets
	Our other intangible assets arose primarily from the acquisitions described above and consist of a brand, the carrier network, distributor relationships, customer relationships, noncompete agreements and capitalized software. Finite-lived intangible assets are amortized over their useful lives from two to fifteen years.
	Major classes of intangible assets as of September 30, 2014 consisted of the following ($ in thousands):
		Weighted-average Amortization (years)		Gross Carrying Amount		Accumulated Amortization			Intangible Assets, net
	Software and technology		6.7	$	8,671	$	(627	)	$	8,044
	Brand		2		1,376		(208	)		1,168
	Noncompete agreements		4.7		986		(408	)		578
	Carrier network		5		40		(24	)		16
	Distributor relationships		9.7		5,496		(1,643	)		3,853
	Customer relationships		2		1,045		(497	)		548
	Total intangible assets		6.9	$	17,614	$	(3,407	)	$	14,207
	Major classes of intangible assets as of December 31, 2013 consisted of the following ($ in thousands):
		Weighted-average Amortization (years)		Gross Carrying Amount		Accumulated Amortization			Intangible Assets, net
	Software and technology		2.2	$	571	$	(134	)	$	437
	Brand		2		76		(17	)		59
	Noncompete agreements		4.8		942		(254	)		688
	Carrier network		5		40		(18	)		22
	Distributor relationships		8.8		4,660		(1,192	)		3,468
	Customer relationship		2		788		(181	)		607
	Total intangible assets		6.9	$	7,077	$	(1,796	)	$	5,281
	Amortization expense for the three months ended September 30, 2014 and 2013 was $862,000 and $391,000, respectively, and for the nine months ended September 30, 2014 and 2013 was $1,612,000 and $842,000, respectively.
	Estimated annual pretax amortization of intangible assets for the remainder of 2014 and in each of the next five years are as follows ($ in thousands):
	Remainder of 2014	$	876
	2015		3,187
	2016		2,416
	2017		1,910
	2018		1,670
	2019		1,283
	Thereafter		2,865
	Total	$	14,207

Accounts_Payable_and_Accrued_E

Accounts Payable and Accrued Expenses	9 Months Ended
	Sep. 30, 2014
Payables And Accruals [Abstract]	'
Accounts Payable and Accrued Expenses	'
	5. Accounts Payable and Other Liabilities
	Accounts payable and accrued expenses consisted of the following as of ($ in thousands):
		30-Sep-14		31-Dec-13
	Accounts payable	$	755	$	588
	Carriers and vendors payable		5,735		3,310
	Commissions payable		2,077		1,453
	Accrued wages		1,688		793
	Accrued refunds		800		715
	Accrued credit card/ACH fees		142		80
	Accrued interest		1		35
	Accrued professional fees		169		34
	Other accruals		911		66
	Total accounts payable and accrued expenses	$	12,278	$	7,074

Stockholders_Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2014
Stockholders Equity Note [Abstract]	'
Stockholders' Equity	'
	6. Stockholders’ Equity
	On February 13, 2013, we completed our IPO by issuing 4,666,667 shares of our Class A common stock, par value $0.001 per share, at a price to the public of $14.00 per share of Class A common stock. In addition, we issued 8,666,667 shares of our Class B common stock, of which 8,580,000 shares of Class B common stock were obtained by HPI, and 86,667 shares of Class B common stock were obtained by Health Plan Intermediaries Sub, LLC (“HPIS”), of which HPI is the managing member. In addition, we granted the underwriters of the IPO the right to purchase additional shares of Class A common stock to cover over-allotments (the “over-allotment option”).
	Our authorized capital stock consists of 100,000,000 shares of Class A common stock, par value $0.001 per share, 20,000,000 shares of Class B common stock, par value $0.001 per share, and 5,000,000 shares of preferred stock, par value $0.001 per share.
	Class A Common Stock and Class B Common Stock
	Each share of Class A common stock and Class B common stock entitles its holders to one vote per share on all matters to be voted upon by the stockholders, and holders of each class will vote together as a single class on all such matters. Holders of shares of our Class A common stock and Class B common stock vote together as a single class on all matters presented to our stockholders for their vote or approval, expect as otherwise required by applicable law. As of September 30, 2014, the Class A common stockholders had 53.4% of the voting power in HII and the Class B common stockholders had 46.6% of the voting power in HII. Holders of shares of our Class A common stock have 100% of the economic interest in HII. Holders of Class B common stock do not have an economic interest in HII.
	The determination to pay dividends, if any, to our Class A common stockholders will be made by our board of directors. We do not, however, expect to declare or pay any cash or other dividends in the foreseeable future on our Class A common stock, as we intend to reinvest any cash flow generated by operations in our business. We may enter into credit agreements or other borrowing arrangements in the future that prohibit or restrict our ability to declare or pay dividends on our Class A common stock. In the event of liquidation, dissolution, or winding up of HII, the holders of Class A common stock are entitled to share ratably in all assets remaining after payment of liabilities, subject to prior distribution rights of preferred stock, if any, then outstanding. The holders of our Class A common stock have no preemptive or conversion rights or other subscription rights. There are no redemption or sinking fund provisions applicable to the Class A common stock. The rights, preferences and privileges of holders of our common stock will be subject to those of the holders of any shares of our preferred stock we may issue in the future.
	Class B common stockholders will not be entitled to any dividend payments. In the event of any dissolution, liquidation, or winding up of our affairs, whether voluntary or involuntary, after payment of our debts and other liabilities and making provision for any holders of our preferred stock that have a liquidation preference, our Class B common stockholders will not be entitled to receive any of our assets. In the event of our merger or consolidation with or into another company in connection with which shares of Class A common stock and Class B common stock (together with the related membership interests) are converted into, or become exchangeable for, shares of stock, other securities or property (including cash), each Class B common stockholder will be entitled to receive the same number of shares of stock as is received by Class A common stockholders for each share of Class A common stock, and will not be entitled, for each share of Class B common stock, to receive other securities or property (including cash). No holders of Class B common stock will have preemptive rights to purchase additional shares of Class B common stock.
	Exchange Agreement
	On February 13, 2013, we entered into an exchange agreement (the “Exchange Agreement”) with the holders of the Series B Membership Interests of HPIH (“Series B Membership Interests”). Pursuant to and subject to the terms of the Exchange Agreement and the amended and restated limited liability company agreement of HPIH, holders of Series B Membership Interests, at any time and from time to time, may exchange one or more Series B Membership Interests, together with an equal number of shares of our Class B common stock, for shares of our Class A common stock on a one-for-one basis, subject to equitable adjustments for stock splits, stock dividends and reclassifications. See Note 1 from our December 31, 2013 audited consolidated financial statements included in our Form 10-K for the year ended December 31, 2013 for further information on the Exchange Agreement.
	In accordance with the Exchange Agreement, in March 2013, we received $1.4 million in proceeds from the issuance of 100,000 shares of Class A common stock through the underwriter’s exercise of its over-allotment option in connection with our IPO. We immediately used the proceeds to acquire Series B Membership Interests, together with an equal number of shares of our Class B common stock from HPI. These Series B Membership Interests were immediately recapitalized into Series A Membership Interests in HPIH.
	On February 1, 2014, a registration statement on Form S-3 became effective under which we registered 8,566,667 shares of our Class A common stock for resale from time to time by the selling stockholder, of which all such shares are issuable upon the exchange of an equivalent number of Series B Membership Interests (together with an equal number of shares of our Class B common stock).
	On August 15, 2014, we entered into an underwriting agreement with Raymond James & Associates, Inc., as the underwriter, and HPI and HPIS, as selling stockholders (the “Selling Stockholders”).  Pursuant to the underwriting agreement and the Exchange Agreement, we issued 1,725,000 shares of Class A common stock, at a public offering price of $12.15 per share ($11.54 per share, net of underwriting discounts), for net proceeds of $19.9 million.  We immediately used these proceeds to acquire Series B Membership Interests, together an equal number of shares of our Class B common stock from HPI and HPIS.  These Series B Membership Interests were immediately recapitalized into Series A Membership Interests in HPIH. The Selling Stockholders agreed to sell to the underwriter for resale all 1,725,000 shares of Class A common stock.  No shares were sold by the Company in this offering, and the Company did not receive any of the proceeds from the sale by the Selling Stockholders.  The sale by the Selling Stockholders was made pursuant to the registration statement on Form S-3 described above.  No other shares of Class A common stock have been issued or sold pursuant to the registration statement on Form S-3.
	Preferred Stock
	Our board of directors has the authority to issue shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, redemption prices, liquidation preferences and the number of shares constituting any series or the designation of such series, without further vote or action by the stockholders.
	The issuance of preferred stock may have the effect of delaying, deferring or preventing a change in control of HII without further action by the stockholders and may adversely affect the voting and other rights of the holders of common stock. At present, we have no plans to issue any preferred stock.
	Treasury Stock
	Treasury stock is recorded at cost and arises pursuant to the surrender of shares by certain employees to satisfy statutory tax withholding obligations on vested restricted stock awards. In addition, certain restricted stock awards have been granted from shares in Treasury. During the three and nine months ended September 30, 2014, 11,542 and 22,286 shares, respectively, were transferred to Treasury as a result of surrendered shares of vested restricted stock awards, and 150,000 shares were granted to employees from Treasury as restricted stock awards during the three and nine months ended September 30, 2014. As of September 30, 2014, we had 2,167 shares of treasury stock, carried at an aggregate cost of $27,000. As of September 30, 2013, we had 32,477 shares of treasury stock, carried at a cost of $377,000. These shares were repurchased pursuant to the surrender of shares by certain employees to satisfy tax withholdings obligations on vested restricted stock awards.

Stockbased_Compensation

Stock-based Compensation	9 Months Ended
	Sep. 30, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'
Stock-based Compensation	'
	7. Stock-based Compensation
	We maintain one stock-based incentive plan, the Health Insurance Innovations, Inc. Long Term Incentive Plan (the “LTIP”), which became effective February 7, 2013, under which restricted shares, stock appreciation rights (“SARs”), stock options and other types of equity and cash incentive awards may be granted to employees, non-employee directors and service providers. The LTIP expires after ten years, unless prior to that date the maximum number of shares available for issuance under the plan has been issued or our board of directors terminates this plan. There were 1,250,000 shares of Class A common stock reserved for issuance under the LTIP.
	Expense for stock-based compensation is recognized based upon estimated grant date fair value and is amortized over the service period of the awards using the accelerated method. For grants of SARS or options, we apply the Black-Scholes option-pricing model in determining the fair value of share-based payments to employees. The resulting compensation expense is recognized over the period. Compensation expense is recognized only for those awards expected to vest. All stock-based compensation expense is classified within selling, general and administrative expense in the consolidated statements of operations. None of the stock-based compensation was capitalized during the three and nine months ended September 30, 2014 and 2013, respectively.
	During the three and nine months ended September 30, 2014, 218,000 and 273,000 SARs were granted, 84,909 Replacement Options were granted to certain holders of options to purchase HP capital stock, and 150,000 restricted shares were issued. The expected term of the awards represents the estimated period of time until exercise, giving consideration to the contractual terms, vesting schedules and expectations of future employee behavior. For the three and nine months ended September 30, 2014 and 2013, the expected stock price volatility was determined using a peer group of public companies within our industry as we believe this method better approximates the long-term volatility of our stock. In the short time since our IPO, our stock has been subject to large fluctuations due to a small percentage of shares available for trading, resulting in a low trading volume. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant with an equivalent remaining term. We have not paid dividends in the past and do not currently plan to pay any dividends in the foreseeable future.
	The Black-Scholes option-pricing model was used with the following weighted average assumptions:
		Nine months ended
		September 30,
		2014			2013
	Risk-free interest rate		1.6	%		0.9	%
	Expected option life	4.9 years			4.5 years
	Expected volatility		40.7	%		45.5	%
	Expected dividend yield	none			none
	The following table summarizes restricted shares, SARs, and stock options granted during the three and nine months ended September 30, 2014 and 2013 (in thousands):
		Three months ended						Nine months ended
		September 30,						September 30,
		2014			2013			2014		2013
	SARs issued		218			20			273		170
	Restricted shares issued		150			—			150		543
	Stock options issued		85			—			85		—
	During the three and nine months ended September 30, 2014, there were 28,000 outstanding awards that were forfeited, of which 13,000 were unvested. No SARS were exercised during the nine months ended September 30, 2014. There were no forfeitures and no SARS were exercised during the nine months ended September 30, 2013.
	The following table summarizes stock-based compensation expense for the three and nine months ended September 30, 2014 and 2013 ($ in thousands):
		Three months ended						Nine months ended
		September 30,						September 30,
		2014			2013			2014		2013
	SARs	$	408		$	184		$	806	$	478
	Restricted shares		166			1,391			533		3,798
	Stock options		269			—			269		—
		$	843		$	1,575		$	1,608	$	4,276
	The following table summarizes unrecognized stock-based compensation and the remaining weighted average period over which such stock-based compensation is expected to be recognized as of September 30, 2014 ($ in thousands):
					Remaining years
	SARs	$	1,733			2.5
	Restricted shares		2,495			2.6
	Stock options		835			1.4
		$	5,063
	The amounts in the table above do not include the cost of any additional awards that may be granted in future periods.
	For the nine months ended September 30, 2014 and 2013, the settlement of stock based incentive plans resulted in a cash outflow of $257,000 and $377,000, respectively, with respect to shares redeemed to cover the recipient’s tax obligations. We recognized an income tax benefit of $33,000 and $84,000 from stock-based activity for the three and nine months ended September 30, 2014. We did not have any income tax benefits realized from this activity for the three and nine months ended September 30, 2013, respectively.

Net_Loss_Income_per_Share

Net (Loss) Income per Share	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Net (Loss) Income per Share	'
	8. Net (Loss) Income per Share
	The computations of basic and diluted net (loss) income per share attributable to Health Insurance Innovations, Inc. for the three and nine months ended September 30, 2014 and 2013 were as follows ($ in thousands, except share and per share data):
		Three months ended September 30,					Nine months ended September 30,
		2014			2013		2014			2013
	Basic net (loss) income attributable to Health Insurance Innovations, Inc.	$	(612	)	$	408	$	(413	)	$	(3,684	)
	Average shares—basic		6,532,161			4,795,736		5,538,422			4,768,294
	Effect of dilutive securities:
	Restricted shares		—			65,600		—			—
	Average shares—diluted		6,532,161			4,861,336		5,538,422			4,768,294
	Basic net (loss) income per share attributable to Health Insurance Innovations, Inc.	$	(0.09	)	$	0.09	$	(0.07	)	$	(0.77	)
	Diluted net (loss) income per share attributable to Health Insurance Innovations, Inc.	$	(0.09	)	$	0.08	$	(0.07	)	$	(0.77	)
	Potential common shares are included in the diluted per share calculation when dilutive. Potential common shares consist of Class A common stock issuable through unvested restricted stock grants and stock appreciation rights and are calculated using the treasury stock method. There is no effect on our restricted stock, stock options and SARs in the computation of diluted earnings per share for the three months ended September 30, 2014 and nine months ended September 30, 2014 and 2013 due to a net loss in those periods.
	The following securities were not included in the calculation of diluted net income (loss) per share because such inclusion would be anti-dilutive (in thousands):
		Three months ended September 30,					Nine months ended September 30,
		2014			2013		2014			2013
	Restricted shares		282			385		282			405
	SARs		559			120		559			120
	Stock options		84			—		84			—

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	9. Income Taxes
	Our subsidiary, HPIH, operates in the United States as a partnership for U.S. federal and state income tax purposes, where taxation is the responsibility of its partners. As a partner in HPIH, we are subject to U.S. corporate federal, state and local income taxes that are reflected in our consolidated financial statements. The effective tax rate for the three and nine months ended September 30, 2014 was 29.7% and 80.7%, respectively. The effective tax rate for the nine months ended September 30, 2013 was (6.4%). Benefit for income taxes was $332,000 and $823,000 for the three months ended September 30, 2014 and 2013, respectively. Benefit for income taxes was $205,000 for the nine months ended September 30, 2014, compared to a provision for income taxes of $472,000 for the nine months ended September 30, 2013. The effective tax rate for the three and nine months ended September 30, 2013 was significantly impacted by expenses for stock-based compensation that were not yet forecasted to be deductible for tax purposes. During the three and nine months ended September 30, 2014, the effective tax rate was significantly impacted by a change in the valuation allowance provided against our deferred tax assets as a result of obligations under the Tax Receivable Agreement (“TRA”), described below, that will permit certain tax benefits to be realized.
	During any period, our effective tax rate also is reduced because certain of our subsidiaries operate as limited liability companies which are not subject to federal or state income tax. Accordingly, a portion of our earnings or losses attributable to noncontrolling interests are not subject to corporate level taxes.  Additionally, our effective tax rate during any period includes a valuation allowance placed on our deferred tax assets, as we believe it is more likely than not that some of our deferred tax assets will not be realized to offset future taxable income.
	We evaluate quarterly the positive and negative evidence regarding the realization of net deferred tax assets. The carrying value of our net deferred tax assets is based on our belief that it is more likely than not that we will be unable to realize some of these deferred tax assets.  As of September 30, 2014, we have determined that it is more likely than not that some of our deferred tax assets will not be realized due to the presence of losses in the only two fiscal years in which we have measured deferred tax assets.  As such, we have provided a valuation allowance against some of our deferred tax assets as of September 30, 2014.  However, we have determined that certain of the deferred tax assets related to our obligations under the TRA would be realizable (as described under Note 10), and have reduced our valuation allowance related to this portion of the deferred tax assets.  We have also recorded a liability payable pursuant to the TRA on our condensed consolidated balance sheets.
	We project to have a current tax liability for the year resulting from our forecasted results from operations, which results primarily from expenses not currently deductible for income tax purposes. We do not project that the current tax liability will enable a significant portion of our deferred tax assets to be realized, and as such, the tax benefit that ordinarily accompanies a deferred tax asset is not available to offset the tax expense from our projected current tax liability.  However, our projected current tax liability will enable a portion of the deferred tax assets related to our TRA to be realized, and as such we have recognized the tax benefit associated with such portion of deferred tax assets.
	We account for uncertainty in income taxes using a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained upon audit, including resolution of related appeals or litigation processes, if any. The second step requires us to estimate and measure the tax benefit as the largest amount that is more likely than not to be realized upon ultimate settlement. Such amounts are subjective, as a determination must be made on the probability of various possible outcomes. We reevaluate uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit, and new audit activity. Such a change in recognition and measurement could result in recognition of a tax benefit or an additional tax provision.
	For the three and nine months ended September 30, 2014 and 2013, there was no change to our total gross unrecognized tax benefit. We believe that there will not be a significant increase or decrease to the uncertain tax positions within 12 months of the reporting date.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2014
Commitments And Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	10. Commitments and Contingencies
	Leases
	We lease office spaces to conduct the operations of HPIH and subsidiaries which expire in between 2015 and 2019. The office space operating lease agreements contain rent holidays and rent escalation provisions. Rent holidays and rent escalation provisions are considered in determining straight-line rent expense to be recorded over the lease term. The difference between cash rent payments and straight-line rent expense was $67,000 and $70,000 as of September 30, 2014 and December 31, 2013, respectively. Total rent expense under all operating leases, which includes equipment, was $154,000 and $96,000 for the three month ended September 30, 2014 and 2013, respectively, and $343,000 and $210,000 for the nine months ended September 30, 2014 and 2013, respectively, and is included in selling, general and administrative expenses in the accompanying condensed consolidated statements of operations.
	BimSym Agreements
	On August 1, 2012, we entered into a software assignment agreement with BimSym eBusiness Solutions, Inc. (“BimSym”) for our exclusive ownership of all rights, title and interest in the technology platform (“A.R.I.E.S. System”) developed by BimSym and utilized by us. As a result of the agreement, we purchased the A.R.I.E.S. System, our proprietary sales and member administration platforms, for $45,000 and this purchase was capitalized and recorded as an intangible asset. In connection with this agreement, we simultaneously entered into a master services agreement for the technology, under which we are required to make monthly payments of $26,000 for 5 years. After the five-year term, this agreement automatically renews for one-year terms unless we give 60 days’ notice.
	Additionally, we also entered into an exclusivity agreement with BimSym whereby neither BimSym nor any of its affiliates will create, market or sell a software, system or service with the same or similar functionality as that of the A.R.I.E.S. System and under which we are required to make monthly payments of $16,000 for five years. The present value of these payments was capitalized and recorded as an intangible asset with a corresponding liability on the accompanying condensed consolidated balance sheets.
	Tax Receivable Agreement
	On February 13, 2013, we entered into a TRA with the holders of the HPIH Series B Membership Interests, which holders are beneficially owned by Mr. Kosloske. The agreement requires us to pay to such holders 85% of the cash savings, if any, in U.S. federal, state and local income tax we realize (or are deemed to realize in the case of an early termination payment, a change in control or a material breach by us of our obligations under the TRA) as a result of any possible future increases in tax basis and of certain other tax benefits related to entering into the TRA, including tax benefits attributable to payments under the TRA itself. This is HII’s obligation and not an obligation of HPIH. HII will benefit from the remaining 15% of any realized cash savings. For purposes of the TRA, cash savings in income tax is computed by comparing our actual income tax liability with our hypothetical liability had we not been able to utilize the tax benefits subject to the TRA itself. The TRA became effective upon completion of the IPO and will remain in effect until all such tax benefits have been used or expired, unless HII exercises its right to terminate the TRA for an amount based on the agreed payments remaining to be made under the agreement or HII breaches any of its material obligations under the TRA in which case all obligations will generally be accelerated and due as if HII had exercised its right to terminate the agreement. Any potential future payments will be calculated using the market value of our Class A common stock at the time of the relevant exchange and prevailing tax rates in future years and will be dependent on us generating sufficient future taxable income to realize the benefit. Payments are generally due under the TRA within a specified period of time following the filing of our tax return for the taxable year with respect to which payment of the obligation arises.
	Exchanges of Series B Membership Interests, together with an equal number of shares of our Class B common stock, for shares of our Class A common stock, are expected to increase our tax basis in our share of HPIH’s tangible and intangible assets. These increases in tax basis are expected to increase our depreciation and amortization deductions and create other tax benefits and therefore may reduce the amount of tax that we would otherwise be required to pay in the future.  As of September 30, 2014, Series B Membership Interests, together with an equal number of shares of Class B common stock have been exchanged for of a total of 1,825,000 shares of Class A common stock subsequent to the IPO. See Note 6 for further information on these issuances of Class A common stock.  As of result of the exchanges noted above, we have recorded a liability of $616,000 pursuant to the TRA as of September 30, 2014.  We have determined that some of this amount is probable to be paid, because a portion of the deductions and other tax benefits noted above will be utilized based on our estimated taxable income for 2014.  Therefore we have also reversed a portion of the valuation allowance on our deferred tax assets related the TRA.  The exchange transactions created a tax benefit to be shared by the Company and the entities beneficially owned by Mr. Kosloske.  Our total liability pursuant to the TRA for exchange transactions completed through September 30, 2014 would be $10.8 million, representing the share of tax benefits payable to the entities beneficially owned by Mr. Kosloske, if we generate sufficient taxable income in the future.  We have made no payments under the TRA as of September 30, 2014.  See Note 9 for further information on the income tax implications of the TRA.
	Distributor Commission Advance
	From time to time, we enter into agreements with our distributors to make advanced commission payments to them.  Certain of these agreements include a loan agreement for the purposes of securing the advanced payments we make.  Generally, these loans will be paid by commissions earned by the distributor, as described in the respective agreements.
	In September 2014, we entered into an agreement with one of our distributors, and certain individuals and entities related to this distributor, (collectively, the “Distributor”), to make advances via a variable secured promissory note. The variable secured promissory note executed by the Distributor (the “Note”) provides for advances up to an aggregate amount of $4.8 million, payable in three installments of $1.5 million, $1.5 million, and $1.8 million.  The first advance installment of $1.5 million was made in September 2014 and is included in advanced commissions on accompanying condensed consolidated balance sheets as of September 30, 2014. The latter two installments will be made on the earlier of June 26, 2015 and February 26, 2016, respectively, or the achievement of certain levels of sales of our products, as defined in the Note, on or before such dates.  The Note, which secured the advances matures on April 26, 2017 and bears an interest only upon the occurrence of an event of default, as defined in the Note.  All amounts outstanding, including interest, are due within thirty days of the maturity date, subject to acceleration upon the occurrence of an event of default.
	The advance entitles our distributor to earn bonus commissions for each qualifying sale, as defined in the Note.  Any such bonus commissions earned during the term of the Note will be applied against the outstanding balance payable to us under the Note, in lieu of a cash payment.
	Legal Proceedings
	As of September 30, 2014, we had no significant pending legal proceedings. We are subject to certain legal proceedings and claims that may arise in the ordinary course of business. In the opinion of management, we do not have a potential liability related to any current legal proceedings and claims that would individually, or in the aggregate, have a material adverse effect on our financial condition, liquidity, results of operations, or cash flows.

Fair_Value_Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Measurements	'
	11. Fair Value Measurements
	We measure and report financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (referred to as an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value of our financial assets and liabilities is determined by using three levels of input, which are defined as follows:
	Level 1:	Quoted prices in active markets for identical assets or liabilities
	Level 2:	Quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability
	Level 3:	Unobservable inputs for the asset or liability
	The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
	We utilize the market approach to measure the fair value of our financial assets. As subjectivity exists with respect to many of the valuation techniques, the fair value estimates we have disclosed may not equal prices that we may ultimately realize if the assets are sold or the liabilities are settled with third parties. Below is a description of our valuation methods.
	Investments. Our short-term investments include certificates of deposit. The certificates of deposit have maturities ranging from three months to twelve months. The short-term investments are classified within Level 1 of the fair value hierarchy. Because the carrying values of the investments approximate the fair values, there are no holding gains or losses on these securities.
	Contingent consideration for business acquisition. The contingent consideration related to the acquisition of Secured and ASIA includes periodic cash payments, as described in Note 2, and is valued using external valuation specialists. The inputs include discount rates reflecting the credit risk, and the probability of the underlying outcome of the results required by Secured to receive payment and the nature of such payments. The underlying outcomes are subject to the target results in the respective instruments or agreement. These liabilities are included in Level 3 of the fair value hierarchy.
	Noncompete obligation. Our noncompete obligation, an exclusivity agreement with the developer of the A.R.I.E.S System as described in Note 10 is primarily valued using nonbinding market prices as stated in the agreement that are corroborated by observable market data. The inputs and fair value are reviewed for reasonableness and may be further validated by comparison to publicly available information or compared to multiple independent valuation sources. The noncompete obligation is classified within Level 2 of the fair value hierarchy.
	The carrying amounts of financial assets and liabilities reported in the accompanying consolidated balance sheets for cash and cash equivalents, cash held on behalf of others, accounts receivable, advanced commissions, and accounts payable and accrued expenses as of June 30, 2014 approximate fair value because of the short-term duration of these instruments.
	As of September 30, 2014, our assets and liabilities measured at fair value were as follows ($ in thousands):
					Fair Value Measurement as of September 30, 2014
		Carrying Value as of September 30, 2014			Level 1		Level 2		Level 3
	Assets:
	Certificates of deposit	$	1,843		$	1,843	$	—	$	—
	Liabilities:
	Noncompete obligation	$	504		$	—	$	497	$	—
	Contingent acquisition consideration		4,686			—		—		4,686
		$	5,190		$	—	$	497	$	4,686
	As of December 31, 2013, our assets and liabilities measured at fair value were as follows ($ in thousands):
					Fair Value Measurement as of December 31, 2013
		Carrying Value as of December 31, 2013			Level 1		Level 2		Level 3
	Assets:
	Certificates of deposit	$	7,337		$	7,337	$	—	$	—
	Liabilities:
	Noncompete obligation	$	626		$	—	$	613	$	—
	Contingent acquisition consideration		3,876			—		—		3,876
		$	4,502		$	—	$	613	$	3,876
	A summary of the changes in the fair value of liabilities carried at fair value that have been classified in Level 3 of the fair value hierarchy was as follows ($ in thousands):
		Contingent Acquisition Consideration
	Balance as of January 1, 2014	$	3,876
	Additional contingent consideration		1,220
	Payments		(1,350	)
	Realized loss included in income		60
	Unrealized loss included in income		880
	Total realized and unrealized loss		940
	Balance as of September 30, 2014	$	4,686
	Realized and unrealized loss on the contingent acquisition are included in other expense (income) on the accompanying condensed consolidated statements of operations.

Segments

Segments	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Segments	'
	12. Segments
	Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision-maker, or decision-making group, in deciding how to allocate resources and in assessing our performance. Our chief operating decision-maker is considered to be the chief executive officer (“CEO”). The CEO reviews our financial information in a manner substantially similar to the accompanying condensed consolidated financial statements. In addition, our operations, revenues, and decision-making functions are based solely in the United States. Therefore, management has concluded that we operate in one operating and geographic segment.

Related_Party_Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	13. Related Party Transactions
	Health Plan Intermediaries, LLC
	HPI and its subsidiary HPIS, which are beneficially owned by Mr. Kosloske (our Chairman, CEO and President), are related parties by virtue of their Series B Membership Interests in HPIH, of which we are managing member. During the nine months ended September 30, 2014 and 2013, HPIH paid cash distributions of $1.1 million and $1.6 million, respectively, to these entities related to estimated federal and state income taxes, pursuant to the operating agreement entered into by HPIH and HPI. The distribution made during the nine months ended September 30, 2014 included $916,000 that was accrued as of December 31, 2013. The distribution made during the nine months ended September 30, 2013 consisted of an accrual of $773,000 which was made during the year ended December 31, 2012 and an additional accrual of $171,000 which was made prior to the IPO.
	Tax Receivable Agreement
	As discussed in Note 10, on February 13, 2013, we entered into a TRA with the holders of the HPIH Series B Membership Interests, which holders are beneficially owned by Mr. Kosloske.
	As of September 30, 2014, we have made no such payments under the TRA. As of September 30, 2014, we would be obligated to pay $616,000 pursuant to the TRA, of which $229,000 is included in current liabilities and $387,000 is included in long-term liabilities on the accompanying condensed consolidated balance sheets. As of December 31, 2013, $423,000 was payable pursuant to the TRA and was included in long-term liabilities in our accompanying condensed consolidated balance sheets.  Our total liability pursuant to the TRA for exchange transactions completed through September 30, 2014 would be $10.8 million if we generate sufficient taxable income in the future.
	Health Benefits One, LLC
	In October 2013, HPIH formed SIL with HBO, one of our distributors. See Note 3 for more information on this joint venture. HBO is a related party by virtue of its 50% ownership of membership interests in SIL. During the three months ended September 30, 2014 and 2013, we made net advanced commissions payments of $103,000 and $52,000, respectively, and recognized $1.5 million and $289,000, respectively, of commission expense related to HBO. During the nine months ended September 30, 2014 and 2013, we made net advanced commissions payments of $631,000 and $153,000, respectively, and recognized $3.5 million and $465,000, respectively, of commission expense related to HBO. As of September 30, 2014 and December 31, 2013, the advanced commissions balances related to HBO included in the accompanying condensed consolidated balance sheets were $1.1 million and $457,000, respectively.
	TSG Agency, LLC
	TSG was a related party by virtue of its involvement in ICE, as described in Note 2. On March 14, 2013, we terminated our contract rights with TSG for an aggregate cash price of $5.5 million. In conjunction with the transaction, Ivan Spinner, TSG’s principal, joined HII as an employee.
	On June 30, 2013, we purchased TSG’s interest in ICE for a cash payment to TSG of $90,000. See Note 2 for further information on this transaction.
	On March 15, 2014, Mr. Spinner’s employment agreement with HII was terminated.

Organization_Basis_of_Presenta1

Organization, Basis of Presentation and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2014
Organization Consolidation And Presentation Of Financial Statements [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	The condensed consolidated financial statements reflect the results of operations of HPI through the closing of the IPO on February 13, 2013, and the Company subsequent to the IPO. Intercompany accounts and transactions have been eliminated in consolidation.
	Noncontrolling interests are included in the consolidated balance sheets as a component of stockholders’ equity that is not attributable to the equity of the Company. We report separately the amounts of consolidated net loss or income attributable to us and noncontrolling interests.
	As an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), we take advantage of certain temporary exemptions from various reporting requirements, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act and reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. We have also elected to delay the adoption of new and revised accounting standards until those standards would otherwise apply to nonpublic entities. Our financial statements may therefore not be comparable to those of companies that comply with such new or revised accounting standards. These exemptions will apply for a period of five years following the completion of our IPO. However, if the market value of our common stock that is held by non-affiliates exceeds $700 million as of any June 30 before that time, we would cease to be an emerging growth company as of the following December 31.
	The information included in this Quarterly Report on Form 10-Q, including the interim condensed consolidated financial statements and the accompanying notes, should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.
Reclassifications	'
	Reclassifications
	Certain amounts in the prior period’s consolidated financial statements have been reclassified to conform to the current period presentation. Such reclassifications include short-term loans receivable into advanced commissions; carriers and vendors payable and commissions payable into accounts payable and accrued expenses; and the long-term portion of the noncompete obligation into other liabilities in the accompanying consolidated balance sheets.
Use of Estimates	'
	Use of Estimates
	The accompanying unaudited interim condensed consolidated financial statements of the Company include all normal recurring accruals and adjustments considered necessary by management for their fair presentation in conformity with accounting principles generally accepted in the United States of America (“GAAP”). Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates. The consolidated results of operations for the three and nine months ended September 30, 2014 are not necessarily indicative of results that may be expected for the year ending December 31, 2014 or any future interim period.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	In the following summary of recent accounting pronouncements, all references to effective dates of Financial Accounting Standards Board (“FASB”) guidance relate to nonpublic entities. As noted above, we have elected to delay the adoption of new and revised accounting standards until those standards would otherwise apply to nonpublic companies under provisions of the JOBS Act.
	In May 2014, the FASB issued an amendment to its accounting guidance related to revenue recognition. The amendment clarifies the principles for recognizing revenue. The guidance is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in the judgments and assets recognized from costs incurred to obtain or fulfill a contract. We will adopt this guidance in reporting periods beginning after December 15, 2017. We are currently evaluating the impact of adopting this pronouncement on our consolidated financial statements.
	In July 2013, the FASB issued guidance which states that a liability for uncertain tax positions, or a portion of a liability for uncertain tax provisions, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available as of the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, liability for uncertain tax positions should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The assessment of whether a deferred tax asset is available is based on the uncertain tax position and deferred tax asset that exist at the reporting date and should be made presuming disallowance of the tax position at the reporting date. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2014, with early adoption permitted. We plan to adopt this guidance during the quarter ended March 31, 2015, but we do not anticipate that it will have a significant impact on our consolidated financial statements.

Business_Acquisitions_Tables

Business Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2014
HealthPocket, Inc	'
Summary of Fair Value of Consideration for Acquisition	'
	The following table summarizes the fair value of the consideration for the acquisition as of July 14, 2014 ($ in thousands):
	Cash paid at closing (1)	$	21,906
	Class A common stock, at fair value (2)		7,126
	Total consideration	$	29,032
	-1	Cash paid at closing includes $17.0 million in cash, $3.2 million in cash held in escrow, as noted above, $1.2 million for the payoff of outstanding bank debt held by HP, $54,000 for the payoff of HP loans payable to Telkamp and Wang, and $482,000 in estimated acquisition-related expenses incurred by HP.
	-2	The fair value of the Class A common stock derived from the market price of the stock, adjusted to include a discount for a lack of marketability, due to trading restrictions pursuant to the Merger Agreement and other factors.
Summary of Allocation of Total Purchase Prices of Acquisition	'
	The following table summarizes the preliminary allocation of the total purchase price for the acquisition as of July 14, 2014 ($ in thousands):
	Cash	$	1,295
	Accounts receivable and other assets (1)		103
	Property and equipment (1)		7
	Accounts payable, accrued expenses and other liabilities (1)		(486	)
	Intangible asset – technology		8,100
	Intangible asset – brand		1,280
	Intangible asset – customer relationships		430
	Intangible asset – noncompete agreements		27
	Goodwill (2)		18,276
		$	29,032
	-1	The carrying value of accounts receivable, accounts payable, accrued expenses and property and equipment approximated fair value; as such, no adjustments to the accounts were recorded in association with the acquisition.
	-2	As of September 30, 2014, we expect none of the goodwill acquired in this transaction to be deductible.
Unaudited Pro Forma Information for Company Assuming Acquisition	'
	The following table ($ in thousands) presents unaudited pro forma information for the Company assuming the acquisition of HP had occurred as of January 1, 2013. This pro forma information does not purport to represent what our actual results would have been if the acquisition had occurred as of the date indicated or what such results would be for any future periods.
		($ in thousands, except per share data)
		Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Revenues	$	23,409		$	14,749		$	62,936		$	40,818
	Net loss before income taxes		(788	)		(1,706	)		(2,175	)		(11,637	)
	Net loss		(554	)		(1,815	)		(420	)		(12,382	)
	Net loss attributable to Health Insurance Innovations, Inc.		(582	)		(1,055	)		(728	)		(5,584	)
	Loss per share – basic		(0.09	)		(0.22	)		(0.13	)		(1.17	)
	Loss per share – diluted		(0.09	)		(0.22	)		(0.13	)		(1.17	)
American Service Insurance Agency, LLC	'
Summary of Fair Value of Consideration for Acquisition	'
	The following table summarizes the fair value of the consideration for the acquisition as of August 8, 2014 ($ in thousands):
	Cash paid at closing	$	1,825
	Contingent consideration, at fair value		1,220
	Total consideration	$	3,045
Summary of Allocation of Total Purchase Prices of Acquisition	'
	The following table summarizes the preliminary allocation of the total purchase price for the acquisition as of August 8, 2014 ($ in thousands):
	Cash	$	105
	Accounts receivable and other assets (1)		272
	Accounts payable, accrued expenses and other liabilities  (1)		(164	)
	Intangible asset – customer relationships – distributors		406
	Intangible asset – customer relationships – direct		257
	Intangible asset – brand		20
	Intangible asset – noncompete agreements		17
	Goodwill (2)		2,132
		$	3,045
	-1	The carrying value of accounts receivable, accounts payable, accrued expenses and property and equipment approximated fair value; as such, no adjustments to the accounts were recorded in association with the acquisition.
	-2	As of September 30, 2014, the amount of goodwill acquired that we expect to be deductible for income tax purposes is $2.1 million.
Unaudited Pro Forma Information for Company Assuming Acquisition	'
	The following table ($ in thousands) presents unaudited pro forma information for the Company assuming the acquisition of ASIA had occurred as of January 1, 2013. This pro forma information does not purport to represent what our actual results would have been if the acquisition had occurred as of the date indicated or what such results would be for any future periods.
		($ in thousands, except per share data)
		Three months ended September 30,						Nine months ended September 30,
		2014			2013			2014			2013
	Revenues	$	23,588		$	15,230		$	63,328		$	42,034
	Net loss before income taxes		(1,258	)		(168	)		(244	)		(6,988	)
	Net (loss) income		(884	)		(179	)		(47	)		(7,435	)
	Net (loss) income attributable to Health Insurance Innovations, Inc.		(624	)		(372	)		(355	)		(3,520	)
	(Loss) income per share – basic		(0.10	)		(0.08	)		(0.06	)		(0.74	)
	(Loss) income per share – diluted		(0.10	)		(0.08	)		(0.06	)		(0.74	)
Sunrise Health Plans, Inc. and Affiliates	'
Summary of Fair Value of Consideration for Acquisition	'
	The following table summarizes the fair value of the consideration for the acquisition as of July 17, 2013 ($ in thousands). The fair values are derived using discount rates related to the probability of the Sellers’ meeting the thresholds for payment and other risk factors including credit risk.
	Cash paid at closing	$	10,000
	Contingent consideration		4,872
	Total consideration	$	14,872
Summary of Allocation of Total Purchase Prices of Acquisition	'
	The following table summarizes the allocation of the total purchase prices for the acquisition as of July 17, 2013 ($ in thousands):
	Cash	$	91
	Accounts receivable and other assets (1)		332
	Property and equipment (1)		128
	Accounts payable and accrued expenses  (1)		(326	)
	Intangible asset – brand		76
	Intangible asset – noncompete agreements		99
	Intangible asset – customer relationships-distributors		1,050
	Intangible asset – customer relationships-direct		788
	Intangible asset – capitalized software		526
	Goodwill (2)		12,108
		$	14,872
	-1	The carrying value of accounts receivable, property and equipment and accounts payable and accrued expenses acquired approximated fair value; as such, no adjustments to these accounts were recorded in association with the acquisition.
	-2	As of September 30, 2014, the amount of goodwill acquired that we expect to be deductible for income tax purposes is $8.9 million.
Unaudited Pro Forma Information for Company Assuming Acquisition	'
	The following table ($ in thousands) presents unaudited pro forma information for the Company assuming the acquisition of Secured had occurred as of January 1, 2013. This pro forma information does not purport to represent what our actual results would have been if the acquisition had occurred as of the date indicated or what such results would be for any future periods.
		Three months ended September 30, 2013			Nine months ended September 30, 2013
	Revenues	$	15,162		$	43,383
	Net income (loss) before income taxes		(209	)		(5,491	)
	Net income (loss)		(226	)		(5,885	)
	Net income (loss) attributable to Health Insurance Innovations, Inc.		(93	)		(1,219	)
	Income (loss) per share – basic		(0.02	)		(0.26	)
	Income (loss) per share – diluted		(0.02	)		(0.26	)

Goodwill_and_Intangible_Assets1

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2014
Goodwill And Intangible Assets Disclosure [Abstract]	'
Summary of Changes in Carrying Amounts of Goodwill	'
	Our goodwill balance as of December 31, 2013 arose from previous acquisitions as described in our Form 10-K for the year ended December 31, 2013. Our goodwill balance as of September 30, 2014 arose from the HP and the ASIA acquisitions described in Note 2 as well as our goodwill balance existing as prior to such acquisition.
	The changes in the carrying amounts of goodwill were as follows ($ in thousands):
	Balance as of January 1, 2013	$	5,906
	Goodwill acquired		12,108
	Impairment of goodwill		—
	Balance as of December 31, 2013		18,014
	Goodwill acquired		20,408
	Impairment of goodwill		—
	Balance as of September 30, 2014	$	38,422
Schedule of Major Classes of Intangible Assets	'
	Major classes of intangible assets as of September 30, 2014 consisted of the following ($ in thousands):
		Weighted-average Amortization (years)		Gross Carrying Amount		Accumulated Amortization			Intangible Assets, net
	Software and technology		6.7	$	8,671	$	(627	)	$	8,044
	Brand		2		1,376		(208	)		1,168
	Noncompete agreements		4.7		986		(408	)		578
	Carrier network		5		40		(24	)		16
	Distributor relationships		9.7		5,496		(1,643	)		3,853
	Customer relationships		2		1,045		(497	)		548
	Total intangible assets		6.9	$	17,614	$	(3,407	)	$	14,207
	Major classes of intangible assets as of December 31, 2013 consisted of the following ($ in thousands):
		Weighted-average Amortization (years)		Gross Carrying Amount		Accumulated Amortization			Intangible Assets, net
	Software and technology		2.2	$	571	$	(134	)	$	437
	Brand		2		76		(17	)		59
	Noncompete agreements		4.8		942		(254	)		688
	Carrier network		5		40		(18	)		22
	Distributor relationships		8.8		4,660		(1,192	)		3,468
	Customer relationship		2		788		(181	)		607
	Total intangible assets		6.9	$	7,077	$	(1,796	)	$	5,281
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	'
	Estimated annual pretax amortization of intangible assets for the remainder of 2014 and in each of the next five years are as follows ($ in thousands):
	Remainder of 2014	$	876
	2015		3,187
	2016		2,416
	2017		1,910
	2018		1,670
	2019		1,283
	Thereafter		2,865
	Total	$	14,207

Accounts_Payable_and_Accrued_E1

Accounts Payable and Accrued Expenses (Tables)	9 Months Ended
	Sep. 30, 2014
Payables And Accruals [Abstract]	'
Summary of Accounts Payable and Accrued Expenses	'
	Accounts payable and accrued expenses consisted of the following as of ($ in thousands):
		30-Sep-14		31-Dec-13
	Accounts payable	$	755	$	588
	Carriers and vendors payable		5,735		3,310
	Commissions payable		2,077		1,453
	Accrued wages		1,688		793
	Accrued refunds		800		715
	Accrued credit card/ACH fees		142		80
	Accrued interest		1		35
	Accrued professional fees		169		34
	Other accruals		911		66
	Total accounts payable and accrued expenses	$	12,278	$	7,074

Stockbased_Compensation_Tables

Stock-based Compensation (Tables)	9 Months Ended
	Sep. 30, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'
Summary of Weighted Average Assumptions	'
	The Black-Scholes option-pricing model was used with the following weighted average assumptions:
		Nine months ended
		September 30,
		2014			2013
	Risk-free interest rate		1.6	%		0.9	%
	Expected option life	4.9 years			4.5 years
	Expected volatility		40.7	%		45.5	%
	Expected dividend yield	none			none
Summary of SARs and Restricted Shares Granted	'
	The following table summarizes restricted shares, SARs, and stock options granted during the three and nine months ended September 30, 2014 and 2013 (in thousands):
		Three months ended						Nine months ended
		September 30,						September 30,
		2014			2013			2014		2013
	SARs issued		218			20			273		170
	Restricted shares issued		150			—			150		543
	Stock options issued		85			—			85		—
Summary of Stock Based Compensation Expense	'
	The following table summarizes stock-based compensation expense for the three and nine months ended September 30, 2014 and 2013 ($ in thousands):
		Three months ended						Nine months ended
		September 30,						September 30,
		2014			2013			2014		2013
	SARs	$	408		$	184		$	806	$	478
	Restricted shares		166			1,391			533		3,798
	Stock options		269			—			269		—
		$	843		$	1,575		$	1,608	$	4,276
Summary of Unrecognized Stock Based Compensation	'
	The following table summarizes unrecognized stock-based compensation and the remaining weighted average period over which such stock-based compensation is expected to be recognized as of September 30, 2014 ($ in thousands):
					Remaining years
	SARs	$	1,733			2.5
	Restricted shares		2,495			2.6
	Stock options		835			1.4
		$	5,063

Net_Loss_Income_per_Share_Tabl

Net (Loss) Income per Share (Tables)	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Summary of Reconciliation of Numerators and Denominators of Basic and Diluted Net Income (Loss)	'
	The computations of basic and diluted net (loss) income per share attributable to Health Insurance Innovations, Inc. for the three and nine months ended September 30, 2014 and 2013 were as follows ($ in thousands, except share and per share data):
		Three months ended September 30,					Nine months ended September 30,
		2014			2013		2014			2013
	Basic net (loss) income attributable to Health Insurance Innovations, Inc.	$	(612	)	$	408	$	(413	)	$	(3,684	)
	Average shares—basic		6,532,161			4,795,736		5,538,422			4,768,294
	Effect of dilutive securities:
	Restricted shares		—			65,600		—			—
	Average shares—diluted		6,532,161			4,861,336		5,538,422			4,768,294
	Basic net (loss) income per share attributable to Health Insurance Innovations, Inc.	$	(0.09	)	$	0.09	$	(0.07	)	$	(0.77	)
	Diluted net (loss) income per share attributable to Health Insurance Innovations, Inc.	$	(0.09	)	$	0.08	$	(0.07	)	$	(0.77	)
Summary of Securities Not Included in Calculation of Diluted Net Income (Loss)	'
	The following securities were not included in the calculation of diluted net income (loss) per share because such inclusion would be anti-dilutive (in thousands):
		Three months ended September 30,					Nine months ended September 30,
		2014			2013		2014			2013
	Restricted shares		282			385		282			405
	SARs		559			120		559			120
	Stock options		84			—		84			—

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Summary of Assets and Liabilities Measured at Fair Value	'
	As of September 30, 2014, our assets and liabilities measured at fair value were as follows ($ in thousands):
					Fair Value Measurement as of September 30, 2014
		Carrying Value as of September 30, 2014			Level 1		Level 2		Level 3
	Assets:
	Certificates of deposit	$	1,843		$	1,843	$	—	$	—
	Liabilities:
	Noncompete obligation	$	504		$	—	$	497	$	—
	Contingent acquisition consideration		4,686			—		—		4,686
		$	5,190		$	—	$	497	$	4,686
	As of December 31, 2013, our assets and liabilities measured at fair value were as follows ($ in thousands):
					Fair Value Measurement as of December 31, 2013
		Carrying Value as of December 31, 2013			Level 1		Level 2		Level 3
	Assets:
	Certificates of deposit	$	7,337		$	7,337	$	—	$	—
	Liabilities:
	Noncompete obligation	$	626		$	—	$	613	$	—
	Contingent acquisition consideration		3,876			—		—		3,876
		$	4,502		$	—	$	613	$	3,876
Summary of the Changes in the Fair Value of Liabilities Carried at Fair Value	'
	A summary of the changes in the fair value of liabilities carried at fair value that have been classified in Level 3 of the fair value hierarchy was as follows ($ in thousands):
		Contingent Acquisition Consideration
	Balance as of January 1, 2014	$	3,876
	Additional contingent consideration		1,220
	Payments		(1,350	)
	Realized loss included in income		60
	Unrealized loss included in income		880
	Total realized and unrealized loss		940
	Balance as of September 30, 2014	$	4,686

Organization_Basis_of_Presenta2

Organization, Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)	9 Months Ended	0 Months Ended	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Aug. 15, 2014	Sep. 30, 2014
		Health Plan Intermediaries Holdings, LLC	Variable Interest Entity, Primary Beneficiary
			Health Plan Intermediaries Holdings, LLC
Organization Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]	'	'	'
Percentage of voting interests	'	100.00%	100.00%
Period of exemptions under JOBS Act	'5 years	'	'
Market value of common stock held by non-affiliates	$700	'	'

Business_Acquisitions_Addition

Business Acquisitions - Additional Information (Detail) (USD $)

3 Months Ended

9 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Jun. 30, 2013

Jun. 01, 2012

Jun. 01, 2012

Sep. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Jul. 14, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Jul. 14, 2014

Aug. 08, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Aug. 08, 2014

Aug. 08, 2014

Aug. 08, 2014

Aug. 08, 2014

Sep. 30, 2014

Sep. 30, 2014

Jul. 17, 2013

Sep. 30, 2014

Nov. 30, 2013

Nov. 30, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Nov. 30, 2013

Nov. 30, 2013

Nov. 30, 2013

Sep. 30, 2014

ICE

HPI

TSG

Replacement Options

Class A common stock

Class A common stock

HealthPocket, Inc

HealthPocket, Inc

HealthPocket, Inc

HealthPocket, Inc

HealthPocket, Inc

American Service Insurance Agency, LLC

American Service Insurance Agency, LLC

American Service Insurance Agency, LLC

American Service Insurance Agency, LLC

American Service Insurance Agency, LLC

American Service Insurance Agency, LLC

American Service Insurance Agency, LLC

American Service Insurance Agency, LLC

Acquisition of American Service Insurance Agency, LLC

Acquisition of American Service Insurance Agency, LLC

Sunrise Health Plans, Inc. and Affiliates

Sunrise Health Plans, Inc. and Affiliates

Sunrise Health Plans, Inc. and Affiliates

Sunrise Health Plans, Inc. and Affiliates

Sunrise Health Plans, Inc. and Affiliates

Sunrise Health Plans, Inc. and Affiliates

Sunrise Health Plans, Inc. and Affiliates

Sunrise Health Plans, Inc. and Affiliates

Sunrise Health Plans, Inc. and Affiliates

Sunrise Health Plans, Inc. and Affiliates

Sunrise Health Plans, Inc. and Affiliates

ICE

ICE

Replacement Options

Class A common stock

Fair Value

Initial payment

Paid at closing

First potential cash payment

Second potential cash payment

Maximum

Fair Value

Fair Value Adjustments

Fair Value Adjustments

One Time Payment

Quarterly Variable Payment

Maximum Potential Variable Payment

Compensation To Income Tax Liability

Controlling Interest

Noncontrolling Interests

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Date of merger agreement with HealthPocket, Inc

'

'

'

'

'

'

'

'

'

'

'

'

14-Jul-14

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash paid at closing

'

'

'

'

'

'

'

'

'

'

$21,906,000

[1]

'

'

'

'

$1,825,000

'

'

'

$1,825,000,000

$1,500,000

'

'

'

'

$10,000,000

'

'

'

'

'

'

'

'

'

'

Class A common stock issued to purchase subsidiary, shares

'

'

'

'

'

'

'

'

815,991

'

'

'

815,991

'

900,900

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock, par value

'

'

'

'

'

'

'

'

$0.00

$0.00

'

'

'

'

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Aggregate value of shares issued for acquisition

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Price per share of shares issued for acquisition

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$11.10

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Merger consideration deposited as escrow deposit

'

'

'

'

'

'

'

'

'

'

3,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total number of replacement Options

'

'

'

'

'

'

'

84,909

'

'

'

'

'

84,909

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of shares former equity holders will take in cash or stock

'

'

'

'

'

'

'

'

'

'

50.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Noncompetition covenant expiration date

'

'

'

'

'

'

'

'

'

'

'

'

14-Jul-17

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revenue from acquiree since acquisition date

'

'

'

'

'

'

'

'

'

'

'

370,000

370,000

'

'

'

292,000

292,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Pre-tax net loss from acquiree since acquisition date

'

'

'

'

'

'

'

'

'

'

'

-1,400,000

-1,400,000

'

'

'

-300,000

-300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amortization expense related to identified intangible assets

862,000

391,000

1,612,000

842,000

'

'

'

'

'

'

'

459,000

459,000

'

'

'

29,000

29,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Merger consideration prior deposit amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

325,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Contingent acquisition consideration

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,200,000

'

'

1,300,000

'

'

'

'

'

'

'

3,800,000

'

'

3,400,000

'

'

'

200,000

2,400,000

150,000

Business acquisition consideration cash payment

'

'

'

'

'

'

'

'

'

'

17,000,000

'

'

'

'

'

'

'

'

'

'

1,200,000

1,000,000

'

'

'

2,800,000

'

'

'

'

'

1,000,000

'

'

'

Fair value adjustments to contingent acquisition consideration

'

'

939,000

64,000

'

'

'

'

'

'

'

'

'

'

'

'

50,000

'

'

'

'

'

'

'

'

'

'

'

'

'

81,000

890,000

'

'

'

'

Potential total contingent consideration, minimum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

'

2,800,000

'

'

'

'

'

'

'

'

'

Potential total contingent consideration, maximum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,200,000

2,200,000

'

'

'

'

'

'

'

6,600,000

6,600,000

'

'

'

'

'

'

'

'

'

Date of employment agreement with jordan

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8-Aug-14

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Expiration date of Agreement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8-Aug-17

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employment contract termination period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'1 year

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Transaction costs for business acquisition

'

'

'

'

'

'

'

'

'

'

'

433,000

520,000

'

'

'

'

'

'

'

'

'

'

13,000

48,000

'

'

'

'

'

'

'

'

'

'

'

Fixed component contingent consideration

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

250,000

3,000,000

'

'

'

'

'

'

'

Ownership percentage

'

'

'

'

20.00%

80.00%

20.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Acquisition of noncontrolling interest in subsidiary

'

'

$0

$90,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

[1]

Cash paid at closing includes $17.0 million in cash, $3.2 million in cash held in escrow, as noted above, $1.2 million for the payoff of outstanding bank debt held by HP, $54,000 for the payoff of HP loans payable to Telkamp and Wang, and $482,000 in estimated acquisition-related expenses incurred by HP.

Business_Acquisitions_Summary_

Business Acquisitions - Summary of Fair Value of Consideration for Acquisition (Detail) (USD $)	0 Months Ended
In Thousands, unless otherwise specified	Jul. 14, 2014		Jul. 14, 2014		Aug. 08, 2014	Aug. 08, 2014	Jul. 17, 2013	Jul. 17, 2013
	HealthPocket, Inc		HealthPocket, Inc		American Service Insurance Agency, LLC	American Service Insurance Agency, LLC	Sunrise Health Plans, Inc. and Affiliates	Sunrise Health Plans, Inc. and Affiliates
			Fair Value			Fair Value		Fair Value
			Class A common stock
Business Acquisition [Line Items]	'		'		'	'	'	'
Cash paid at closing	$21,906	[1]	'		$1,825	'	$10,000	'
Class A common stock, at fair value	'		7,126	[2]	'	'	'	'
Total consideration	29,032		'		3,045	'	14,872	'
Contingent consideration	'		'		'	$1,220	'	$4,872
[1]	Cash paid at closing includes $17.0 million in cash, $3.2 million in cash held in escrow, as noted above, $1.2 million for the payoff of outstanding bank debt held by HP, $54,000 for the payoff of HP loans payable to Telkamp and Wang, and $482,000 in estimated acquisition-related expenses incurred by HP.
[2]	The fair value of the Class A common stock derived from the market price of the stock, adjusted to include a discount for a lack of marketability, due to trading restrictions pursuant to the Merger Agreement and other factors.

Business_Acquisitions_Summary_1

Business Acquisitions - Summary of Fair Value of Consideration for Acquisition (Parenthetical) (Detail) (HealthPocket, Inc, USD $)	0 Months Ended
	Jul. 14, 2014
Business Acquisition [Line Items]	'
Business acquisition consideration cash payment	$17,000,000
Merger consideration deposited as escrow deposit	3,200,000
Acquisition related expenses	482,000
Outstanding bank debt	'
Business Acquisition [Line Items]	'
Contingent consideration	1,200,000
Healthpocket loans payable to Founders	'
Business Acquisition [Line Items]	'
Contingent consideration	$54,000

Business_Acquisitions_Summary_2

Business Acquisitions - Summary of Allocation of Total Purchase Prices for Acquisition (Detail) (USD $)

Sep. 30, 2014

Dec. 31, 2013

Dec. 31, 2012

Jul. 14, 2014

Jul. 14, 2014

Jul. 14, 2014

Jul. 14, 2014

Jul. 14, 2014

Aug. 08, 2014

Aug. 08, 2014

Aug. 08, 2014

Aug. 08, 2014

Aug. 08, 2014

Jul. 17, 2013

Jul. 17, 2013

Jul. 17, 2013

Jul. 17, 2013

Jul. 17, 2013

Jul. 17, 2013

In Thousands, unless otherwise specified

HealthPocket, Inc

HealthPocket, Inc

HealthPocket, Inc

HealthPocket, Inc

HealthPocket, Inc

American Service Insurance Agency, LLC

American Service Insurance Agency, LLC

American Service Insurance Agency, LLC

American Service Insurance Agency, LLC

American Service Insurance Agency, LLC

Sunrise Health Plans, Inc. and Affiliates

Sunrise Health Plans, Inc. and Affiliates

Sunrise Health Plans, Inc. and Affiliates

Sunrise Health Plans, Inc. and Affiliates

Sunrise Health Plans, Inc. and Affiliates

Sunrise Health Plans, Inc. and Affiliates

Technology

Brand

Customer relationships

Noncompete agreements

Noncompete agreements

Customer Relationships-Distributors

Customer Relationships-Direct

Brand

Noncompete agreements

Customer Relationships-Distributors

Customer Relationships-Direct

Brand

Capitalized software

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash

'

'

'

$1,295

'

'

'

'

$105

'

'

'

'

$91

'

'

'

'

'

Accounts receivable and other assets

'

'

'

103

[1]

'

'

'

'

272

[1]

'

'

'

'

332

[2]

'

'

'

'

'

Property and equipment

'

'

'

7

[1]

'

'

'

'

'

'

'

'

'

128

[2]

'

'

'

'

'

Accounts payable and accrued expenses

'

'

'

-486

[1]

'

'

'

'

'

'

'

'

'

-326

[2]

'

'

'

'

'

Intangible asset

'

'

'

'

8,100

1,280

430

27

'

17

406

257

20

'

99

1,050

788

76

526

Goodwill

38,422

18,014

5,906

18,276

[3]

'

'

'

'

2,132

[4]

'

'

'

'

12,108

[5]

'

'

'

'

'

Total consideration

'

'

'

29,032

'

'

'

'

3,045

'

'

'

'

14,872

'

'

'

'

'

Accounts payable, accrued expenses and other liabilities

'

'

'

'

'

'

'

'

($164)

[1]

'

'

'

'

'

'

'

'

'

'

[1]

The carrying value of accounts receivable, accounts payable, accrued expenses and property and equipment approximated fair value; as such, no adjustments to the accounts were recorded in association with the acquisition.

[2]

The carrying value of accounts receivable, property and equipment and accounts payable and accrued expenses acquired approximated fair value; as such, no adjustments to these accounts were recorded in association with the acquisition.

[3]

As of September 30, 2014, we expect none of the goodwill acquired in this transaction to be deductible.

[4]

As of September 30, 2014, the amount of goodwill acquired that we expect to be deductible for income tax purposes is $2.1 million.

[5]

As of SeptemberB 30, 2014, the amount of goodwill acquired that we expect to be deductible for income tax purposes is $8.9 million.

Business_Acquisitions_Summary_3

Business Acquisitions - Summary of Allocation of Total Purchase Prices for Acquisition (Parenthetical) (Detail) (USD $)	Sep. 30, 2014
In Millions, unless otherwise specified
HealthPocket, Inc	'
Business Acquisition [Line Items]	'
Business acquisition, goodwill, expected tax deductible amount	$0
American Service Insurance Agency, LLC	'
Business Acquisition [Line Items]	'
Business acquisition, goodwill, expected tax deductible amount	2.1
Sunrise Health Plans, Inc. and Affiliates	'
Business Acquisition [Line Items]	'
Business acquisition, goodwill, expected tax deductible amount	$8.90

Business_Acquisitions_Unaudite

Business Acquisitions - Unaudited Pro Forma Information for Company Assuming Acquisition (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
HealthPocket, Inc	'	'	'	'
Business Acquisition [Line Items]	'	'	'	'
Revenues	$23,409	$14,749	$62,936	$40,818
Net (loss) income before income taxes	-788	-1,706	-2,175	-11,637
Net (loss) income	-554	-1,815	-420	-12,382
Net (loss) income attributable to Health Insurance Innovations, Inc.	-582	-1,055	-728	-5,584
(Loss) income per share b basic	($0.09)	($0.22)	($0.13)	($1.17)
(Loss) income per share b diluted	($0.09)	($0.22)	($0.13)	($1.17)
American Service Insurance Agency, LLC	'	'	'	'
Business Acquisition [Line Items]	'	'	'	'
Revenues	23,588	15,230	63,328	42,034
Net (loss) income before income taxes	-1,258	-168	-244	-6,988
Net (loss) income	-884	-179	-47	-7,435
Net (loss) income attributable to Health Insurance Innovations, Inc.	-624	-372	-355	-3,520
(Loss) income per share b basic	($0.10)	($0.08)	($0.06)	($0.74)
(Loss) income per share b diluted	($0.10)	($0.08)	($0.06)	($0.74)
Sunrise Health Plans, Inc. and Affiliates	'	'	'	'
Business Acquisition [Line Items]	'	'	'	'
Revenues	'	15,162	'	43,383
Net (loss) income before income taxes	'	-209	'	-5,491
Net (loss) income	'	-226	'	-5,885
Net (loss) income attributable to Health Insurance Innovations, Inc.	'	($93)	'	($1,219)
(Loss) income per share b basic	'	($0.02)	'	($0.26)
(Loss) income per share b diluted	'	($0.02)	'	($0.26)

Variable_Interest_Entities_Add

Variable Interest Entities - Additional Information (Detail) (USD $)	9 Months Ended	11 Months Ended	9 Months Ended	0 Months Ended			0 Months Ended
	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014	Oct. 07, 2013	Aug. 15, 2014	Sep. 30, 2014	Aug. 15, 2014	Aug. 15, 2014
	Class B common stock	Class B common stock	Simple Insurance Leads L L C	Simple Insurance Leads L L C	Health Plan Intermediaries Holdings, LLC	Health Plan Intermediaries Holdings, LLC	Health Plan Intermediaries Holdings, LLC	Health Plan Intermediaries Holdings, LLC
				Subsequent Event			Class B common stock	Minimum
				Maximum
Variable Interest Entity [Line Items]	'	'	'	'	'	'	'	'
Capital contribution	'	'	$469,000	'	'	'	'	'
Expected investments in affiliates subsidiaries associates and joint ventures	'	'	'	492,000	'	'	'	'
Percentage of voting interests	'	'	100.00%	'	100.00%	'	'	50.00%
Variable interest entity maximum loss exposure of contributed capital, percentage	'	'	100.00%	'	'	'	'	'
Variable interest entity maximum loss exposure of operating income, percentage	'	'	100.00%	'	'	'	'	'
Variable Interest Entity, Maximum Loss Exposure, Amount	'	'	$469,000	'	'	'	'	'
Total membership interest without voting right	'	'	'	'	'	53.40%	'	'
Units exchanged	1,725,000	100,000	'	'	'	'	1,725,000	'

Goodwill_and_Intangible_Assets2

Goodwill and Intangible Assets - Summary of Changes in Carrying Amounts of Goodwill (Detail) (USD $)	9 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Goodwill And Intangible Assets Disclosure [Abstract]	'	'
Goodwill Beginning Balance	$18,014	$5,906
Goodwill acquired	20,408	12,108
Impairment of goodwill	0	0
Goodwill Ending Balance	$38,422	$18,014

Goodwill_and_Intangible_Assets3

Goodwill and Intangible Assets - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Goodwill And Intangible Assets Disclosure [Line Items]	'	'	'	'
Amortization expense	$862,000	$391,000	$1,612,000	$842,000
Minimum	'	'	'	'
Goodwill And Intangible Assets Disclosure [Line Items]	'	'	'	'
Finite lived intangible asset useful life	'	'	'2 years	'
Maximum	'	'	'	'
Goodwill And Intangible Assets Disclosure [Line Items]	'	'	'	'
Finite lived intangible asset useful life	'	'	'15 years	'

Goodwill_and_Intangible_Assets4

Goodwill and Intangible Assets - Schedule of Major Classes of Intangible Assets (Detail) (USD $)	9 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Acquired Finite Lived Intangible Assets [Line Items]	'	'
Weighted-average Amortization	'6 years 10 months 24 days	'6 years 10 months 24 days
Gross Carrying Amount	$17,614	$7,077
Accumulated Amortization	-3,407	-1,796
Intangible Asset, net	14,207	5,281
Software and technology	'	'
Acquired Finite Lived Intangible Assets [Line Items]	'	'
Weighted-average Amortization	'6 years 8 months 12 days	'2 years 2 months 12 days
Gross Carrying Amount	8,671	571
Accumulated Amortization	-627	-134
Intangible Asset, net	8,044	437
Brand	'	'
Acquired Finite Lived Intangible Assets [Line Items]	'	'
Weighted-average Amortization	'2 years	'2 years
Gross Carrying Amount	1,376	76
Accumulated Amortization	-208	-17
Intangible Asset, net	1,168	59
Noncompete agreements	'	'
Acquired Finite Lived Intangible Assets [Line Items]	'	'
Weighted-average Amortization	'4 years 8 months 12 days	'4 years 9 months 18 days
Gross Carrying Amount	986	942
Accumulated Amortization	-408	-254
Intangible Asset, net	578	688
Carrier network	'	'
Acquired Finite Lived Intangible Assets [Line Items]	'	'
Weighted-average Amortization	'5 years	'5 years
Gross Carrying Amount	40	40
Accumulated Amortization	-24	-18
Intangible Asset, net	16	22
Distributor relationships	'	'
Acquired Finite Lived Intangible Assets [Line Items]	'	'
Weighted-average Amortization	'9 years 8 months 12 days	'8 years 9 months 18 days
Gross Carrying Amount	5,496	4,660
Accumulated Amortization	-1,643	-1,192
Intangible Asset, net	3,853	3,468
Customer relationships	'	'
Acquired Finite Lived Intangible Assets [Line Items]	'	'
Weighted-average Amortization	'2 years	'2 years
Gross Carrying Amount	1,045	788
Accumulated Amortization	-497	-181
Intangible Asset, net	$548	$607

Goodwill_and_Intangible_Assets5

Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Goodwill And Intangible Assets Disclosure [Abstract]	'	'
Remainder of 2014	$876	'
2015	3,187	'
2016	2,416	'
2017	1,910	'
2018	1,670	'
2019	1,283	'
Thereafter	2,865	'
Intangible Asset, net	$14,207	$5,281

Accounts_Payable_and_Accrued_E2

Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Accounts payable and accrued expenses	'	'
Accounts payable	$755	$588
Carriers and vendors payable	5,735	3,310
Commissions payable	2,077	1,453
Accrued wages	1,688	793
Accrued refunds	800	715
Accrued credit card/ACH fees	142	80
Accrued interest	1	35
Accrued professional fees	169	34
Other accruals	911	66
Total accounts payable and accrued expenses	$12,278	$7,074

Stockholders_Equity_Additional

Stockholders' Equity - Additional Information (Detail) (USD $)

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Aug. 15, 2014

Sep. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Feb. 01, 2014

Feb. 13, 2013

Dec. 31, 2013

Feb. 13, 2013

Dec. 31, 2013

Feb. 13, 2013

Feb. 13, 2013

Treasury Stock

Treasury Stock

Exchange Agreement

Class A common stock

Class A common stock

Class A common stock

Class A common stock

Class B common stock

Class B common stock

Class B common stock

Initial public offering

Initial public offering

Initial public offering

Initial public offering

Initial public offering

Initial public offering

HPI

Hpis

Underwriting Agreement

HII

HII

Class A common stock

Class A common stock

Class A common stock

Class B common stock

Class B common stock

Initial public offering

Initial public offering

Class B common stock

Class B common stock

Class Of Stock [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock, shares

'

'

'

'

'

100,000

'

'

1,725,000

'

'

'

'

'

8,566,667

4,666,667

4,666,667

8,666,667

8,666,667

8,580,000

86,667

Common stock, par value

'

'

'

'

'

'

$0.00

$0.00

'

'

$0.00

$0.00

'

'

'

$0.00

'

'

'

'

'

Common stock price

'

'

'

'

'

'

'

'

$12.15

'

'

'

'

'

'

$14

'

'

'

'

'

Common stock, shares authorized

'

'

'

'

'

'

100,000,000

100,000,000

'

'

20,000,000

20,000,000

'

'

'

'

'

'

'

'

'

Preferred stock, shares authorized

5,000,000

5,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, par value

$0.00

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock voting rights percentage

'

'

'

'

'

'

'

'

'

53.40%

'

'

46.60%

'

'

'

'

'

'

'

'

Economic interest

'

'

'

'

'

'

'

'

'

100.00%

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock

'

'

'

'

'

$1,400,000

'

'

$19,900,000

'

'

'

'

$57,755,000

'

'

$5,000

'

$9,000

'

'

Common stock price

'

'

'

'

'

'

'

'

$11.54

'

'

'

'

'

'

'

'

'

'

'

'

Number of shares transferred to Treasury

'

'

'

11,542

22,286

'

-10,744

-129,881

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares granted from Treasury as restricted stock awards

'

'

'

150,000

150,000

'

-150,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Treasury stock, shares

2,167

129,881

32,477

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Treasury Stock, Carrying Cost

$27,000

$1,563,000

$377,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stockbased_Compensation_Additi

Stock-based Compensation - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'	'
Restricted stock, Shares issued	'	'	150,000	'
Forfeitures share during the period	'	'	28,000	0
Forfeitures of unvested share during the period	'	'	13,000	'
Income tax benefits from stock based activity	$33,000	$0	$84,000	$0
Cash outflows resulting from settlement of stock based incentive plans	'	'	$257,000	$377,000
Stock Appreciation Rights (SARs)	'	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'	'
SARs restricted shares granted	218,000	20,000	273,000	170,000
Stock appreciation rights shares exercises during the period	'	'	0	0
Replacement Options	'	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'	'
Total number of replacement Options	84,909	'	84,909	'
Long Term Incentive Plan	'	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'	'
Common stock reserved for issuance	1,250,000	'	1,250,000	'
Long Term Incentive Plan , Expiration Period	'	'	'10 years	'

Stockbased_Compensation_Summar

Stock-based Compensation - Summary of Weighted Average Assumptions (Detail)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]	'	'
Risk-free interest rate	1.60%	0.90%
Expected option life	'4 years 10 months 24 days	'4 years 6 months
Expected volatility	40.70%	45.50%
Expected dividend yield	0.00%	0.00%

Stockbased_Compensation_Summar1

Stock-based Compensation - Summary of SARs and Restricted Shares Granted (Detail)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Stock Appreciation Rights (SARs)	'	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'	'
SARs restricted shares granted	218,000	20,000	273,000	170,000
Restricted Stock	'	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'	'
SARs restricted shares granted	150,000	'	150,000	543,000
Stock Options	'	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'	'
SARs restricted shares granted	85,000	'	85,000	'

Stockbased_Compensation_Summar2

Stock-based Compensation - Summary of Stock-based Compensation Expenses (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'	'
Stock-based compensation expense	$843	$1,575	$1,608	$4,276
Stock Appreciation Rights (SARs)	'	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'	'
Stock-based compensation expense	408	184	806	478
Restricted Stock	'	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'	'
Stock-based compensation expense	166	1,391	533	3,798
Stock Options	'	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'	'	'	'
Stock-based compensation expense	$269	'	$269	'

Stockbased_Compensation_Summar3

Stock-based Compensation - Summary of Unrecognized Stock-based Compensation (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'
Unrecognized stock-based compensation amount	$5,063
Stock Appreciation Rights (SARs)	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'
Unrecognized stock-based compensation amount	1,733
Stock-based compensation expense amount expected to be recognized	'2 years 6 months
Restricted Stock	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'
Unrecognized stock-based compensation amount	2,495
Stock-based compensation expense amount expected to be recognized	'2 years 7 months 6 days
Stock Options	'
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]	'
Unrecognized stock-based compensation amount	$835
Stock-based compensation expense amount expected to be recognized	'1 year 4 months 24 days

Net_Loss_Income_per_Share_Comp

Net (Loss) Income per Share - Computations of Basic and Diluted Net Income (Loss) Per Share (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Earnings Loss Per Share [Line Items]	'	'	'	'
Basic net (loss) income attributable to Health Insurance Innovations, Inc.	($612)	$408	($413)	($3,684)
Average sharesbbasic	6,532,161	4,795,736	5,538,422	4,768,294
Effect of dilutive securities:	'	'	'	'
Average sharesbdiluted	6,532,161	4,861,336	5,538,422	4,768,294
Basic net (loss) income per share attributable to Health Insurance Innovations, Inc.	($0.09)	$0.09	($0.07)	($0.77)
Diluted net (loss) income per share attributable to Health Insurance Innovations, Inc.	($0.09)	$0.08	($0.07)	($0.77)
Restricted Stock	'	'	'	'
Effect of dilutive securities:	'	'	'	'
Dilutive securities	0	65,600	0	0

Net_Loss_Income_per_Share_Addi

Net (Loss) Income per Share - Additional Information (Detail)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Restricted Stock	'	'	'	'
Earnings Loss Per Share [Line Items]	'	'	'	'
Dilutive securities	0	65,600	0	0
Stock Appreciation Rights (SARs)	'	'	'	'
Earnings Loss Per Share [Line Items]	'	'	'	'
Dilutive securities	0	'	0	0
Stock Options	'	'	'	'
Earnings Loss Per Share [Line Items]	'	'	'	'
Dilutive securities	0	'	0	0

Net_Loss_Income_per_Share_Secu

Net (Loss) Income per Share - Securities Not Included in Diluted Net Income (Loss) per Share (Detail)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Restricted Stock	'	'	'	'
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]	'	'	'	'
Anti-dilutive securities	282	385	282	405
Stock Appreciation Rights (SARs)	'	'	'	'
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]	'	'	'	'
Anti-dilutive securities	559	120	559	120
Stock Options	'	'	'	'
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]	'	'	'	'
Anti-dilutive securities	84	'	84	'

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'	'	'	'
Effective tax rate	29.70%	'	80.70%	-6.40%
(Benefit) provision for income taxes	($332,000)	($823,000)	($205,000)	$472,000
Change in gross unrecognized tax benefit	$0	$0	$0	$0

Commitments_and_Contingencies_

Commitments and Contingencies - Additional Information (Detail) (USD $)

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Feb. 13, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Distributor Promissory Note

Distributor Promissory Note

Distributor Promissory Note

Distributor Promissory Note

Tax Receivable Agreement

Series B Membership Interests

Exclusive Option Agreement

Vendor Contracts

Vendor Contracts

Operating Lease Agreements

Operating Lease Agreements

Operating Lease Agreements

Operating Lease Agreements

Operating Lease Agreements

Shares Issued Under Exchange Agreement

Health Plan Intermediaries Holdings, LLC

Health Plan Intermediaries Holdings, LLC

Second Installment

Third Installment

Tax Receivable Agreement

Software Assignment Agreement

Master Service Agreements

Underwriters Over Allotment Option

Operating Lease Agreements

Operating Lease Agreements

Class A common stock

Minimum

Maximum

Commitment And Contingencies [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Lease agreement expires

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'2015

'2019

Difference between cash rent payments and straight-line rent expense

'

'

'

'

'

'

'

'

'

'

'

'

'

$67,000,000

'

$70,000,000

'

'

'

Operating lease rental expense

'

'

'

'

'

'

'

'

'

'

'

154,000,000

96,000,000

343,000,000

210,000,000

'

'

'

'

System purchase amount

'

'

'

'

'

'

'

'

'

45,000,000

'

'

'

'

'

'

'

'

'

Monthly payment for services agreement for the technology

'

'

'

'

'

'

'

'

16,000,000

'

26,000,000

'

'

'

'

'

'

'

'

Service agreement term

'

'

'

'

'

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

Agreement renewal

'

'

'

'

'

'

'

'

'

'

'one-year terms unless we give 60 daysb

'

'

'

'

'

'

'

'

Exclusive option agreement maturity term

'

'

'

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

'

'

Tax benefit payment, percentage

'

'

'

'

'

'

'

85.00%

'

'

'

'

'

'

'

'

'

'

'

Tax benefit saving, percentage

'

'

'

'

'

'

'

15.00%

'

'

'

'

'

'

'

'

'

'

'

Issuance of common stock, shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,825,000

'

'

Other tax benefits recorded as liability

'

'

'

'

'

'

616,000

'

'

'

'

'

'

'

'

'

'

'

'

Tax receivable agreement liability adjustment

'

'

'

'

'

'

10,800,000

'

'

'

'

'

'

'

'

'

'

'

'

Amount paid under agreement

'

'

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

Variable secured promissory note , advance amount

'

'

4,800,000

4,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Contingent note installment payment

'

'

'

'

1,500,000

1,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Advanced commissions

$5,608,000

$2,596,000

$1,500,000

$1,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Installment payment date description

'

'

'

'The latter two installments will be made on the earlier of June 26, 2015 and February 26, 2016, respectively, or the achievement of certain levels of sales of our products, as defined in the Note, on or before such dates.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note maturity date

'

'

26-Apr-17

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair_Value_Measurements_Summar

Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Carrying Value	'	'
Assets	'	'
Certificates of deposit	$1,843,000	$7,337,000
Liabilities:	'	'
Noncompete obligation	504,000	626,000
Contingent acquisition consideration	4,686,000	3,876,000
Liabilities	5,190,000	4,502,000
Estimate of Fair Value Measurement | Fair Value Measurement Level 1	'	'
Assets	'	'
Certificates of deposit	1,843,000	7,337,000
Estimate of Fair Value Measurement | Fair Value Measurement Level 2	'	'
Liabilities:	'	'
Noncompete obligation	497,000	613,000
Liabilities	497,000	613,000
Estimate of Fair Value Measurement | Fair Value Measurement Level 3	'	'
Liabilities:	'	'
Contingent acquisition consideration	4,686,000	3,876,000
Liabilities	$4,686,000	$3,876,000

Fair_Value_Measurements_Summar1

Fair Value Measurements - Summary of the Changes in the Fair Value of Liabilities Carried at Fair Value (Detail) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'
Additional contingent consideration	$939,000	$64,000
Fair Value Measurement Level 3 | Contingent Acquisition Consideration	'	'
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'
Balance as of January 1, 2014	3,876,000	'
Additional contingent consideration	1,220,000	'
Payments	-1,350,000	'
Realized loss included in income	60,000	'
Unrealized loss included in income	880,000	'
Total realized and unrealized loss	940,000	'
Balance as of September 30, 2014	$4,686,000	'

Segments_Additional_Informatio

Segments - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2014
	Segment
Segment Reporting [Abstract]	'
Number of Operating Segments	1

Related_Party_Transactions_Add

Related Party Transactions - Additional Information (Detail) (USD $)

9 Months Ended

9 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Oct. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Simple Insurance Leads L L C

Tax Receivable Agreement

Tax Receivable Agreement

Health Plan Intermediaries Holdings, LLC

Health Plan Intermediaries Holdings, LLC

Health Plan Intermediaries Holdings, LLC

Health Plan Intermediaries Holdings, LLC

Health Plan Intermediaries Holdings, LLC

Health Benefits One, LLC

Health Benefits One, LLC

Health Benefits One, LLC

Health Benefits One, LLC

Health Benefits One, LLC

Pre IPO

Related Party Transaction [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amount of distributions paid

'

'

'

'

'

'

$1,100,000

$1,600,000

'

'

'

'

'

'

'

'

Related Party Accrued Distribution

229,000

'

916,000

'

'

'

'

'

916,000

773,000

171,000

'

'

'

'

'

Amount paid under agreement

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

Other tax benefits recorded as liability

'

'

'

'

616,000

'

'

'

'

'

'

'

'

'

'

'

Other tax benefits recorded as liability, current

'

'

'

'

229,000

'

'

'

'

'

'

'

'

'

'

'

Other tax benefits recorded as liability, noncurrent

387,000

'

423,000

'

387,000

423,000

'

'

'

'

'

'

'

'

'

'

Tax receivable agreement liability adjustment

'

'

'

'

10,800,000

'

'

'

'

'

'

'

'

'

'

'

Ownership of membership interests

'

'

'

50.00%

'

'

'

'

'

'

'

'

'

'

'

'

Advanced commissions payments, net

'

'

'

'

'

'

'

'

'

'

'

103,000

52,000

631,000

153,000

'

Commission expense, recognized

'

'

'

'

'

'

'

'

'

'

'

1,500,000

289,000

3,500,000

465,000

'

Commissions payable

2,077,000

'

1,453,000

'

'

'

'

'

'

'

'

1,100,000

'

1,100,000

'

457,000

Contract termination

'

5,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Acquisition of noncontrolling interest in subsidiary

$0

$90,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'